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CHAPTER 1.  INTRODUCTION 
 
 Insects pose a significant threat to modern agriculture, causing damage to cash 
and food crops primarily through damage by feeding, but also as vectors of plant 
disease [1].  Every year, insect pests reduce crop production by an estimated 10-16%, 
representing billions of dollars in losses [2,3].  Adding to the cost is the 1.2 billion dollars 
spent on pesticides applied by farmers every year in the United States to manage insect 
pests [3].  These costs could increase further as insect populations increase due to 
global climate change [2,4]. 
Soybean Aphid 
Soybean aphid (Aphis glycines Matsumura) is the foremost pest of soybean in 
North America.  An invasive hemipteran originating from Asia, soybean aphid was first 
identified in the United States in Wisconsin in 2000.  By the end of 2000 it had been 
identified in a total of ten states; by 2009 soybean aphid had been identified in thirty 
states and three Canadian provinces [5].  The soybean aphid requires two host plants, a 
primary host and a secondary host to complete its lifecycle.  In North America the role 
of primary host is fulfilled by common buckthorn (Rhamnus cathartica), an invasive 
species from Europe, as the soybean aphid’s natural primary hosts, Japanese buckthorn 
(Rhamnus japonica) and Dahurian buckthorn (Rhamnus davurica), are not present in 
substantial numbers in North America [5].  Soybean aphids use the primary host for 
sexual reproduction and overwintering.  The secondary host is utilized as the site of 
asexual reproduction; for soybean aphid the secondary host is soybean (Glycines 
max)[5].  Unfortunately, relatively little is known about the molecular biology and 
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physiology of  soybean aphid.  Information on the gut environment is inferred from 
work on other aphid species, while information on the molecular biology of soybean 
aphid is limited to next generation sequencing work [6,7]. 
Soybean aphid infests soybean during the growing season, causing up to a 40% 
yield loss [5].  Damage is caused primarily via feeding, but can also occur by transmission 
of plant viruses, and the deposition of honeydew on the surface of the soybean 
promoting the growth of saprophytic fungi [5,8].  Soybean aphid feeding, as well as the 
growth of fungi on the surface of soybean, interferes with the photosynthetic capability 
of soybean [5,8].  Soybean aphids pose a potential threat as a vector of plant viruses.  
Although soybean aphid has not been linked to viral outbreaks in soybean in North 
America, they have been shown to be competent vectors for several plant viruses 
including Bean yellow mosaic virus, Alfalfa mosaic virus, and Soybean mosaic virus [5,9].  
Management of Soybean Aphid 
A variety of approaches have been taken to manage soybean aphid.  Chemical 
insecticides are both the most traditional approach to soybean aphid management as 
well as the most prevalent.  Foliar application of organophosphates and pyrethroids is a 
common strategy for soybean aphid management [5,8,10].  Neonicotinoid-based seed 
treatments are increasing in popularity for soybean, and can provide some early season 
protection against soybean aphid, although not necessarily the most economical choice 
[5,10].  While insecticides are effective against soybean aphids, insecticide application is 
not without issue.  The use of insecticides increases the cost of soybean production per 
unit area, cutting into the profits of soybean growers [5,10].  Insecticide use can also 
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have an impact on natural enemies of soybean aphid, thereby limiting the beneficial 
effects derived from natural enemies on suppressing soybean aphid populations [5,10].  
The rapid population growth of soybean aphid poses a potential problem for the long-
term use of insecticides.  Under optimal conditions, soybean aphids can double their 
population in less than two days, resulting in upwards of 15 asexual generations per 
season [11]. Rapid population growth increases the risk of soybean aphid developing 
resistance to currently employed insecticides highlighting the importance of the proper 
use of insecticides to preserve their long term efficacy [10].   
The development of naturally resistant plant cultivars provides another strategy 
for the management of soybean aphid.  Natural plant resistance utilizes two 
mechanisms, antibiosis, causing the death of the pest insect, and antixenosis, deterring 
pest feeding [5,10].   A total of four “resistance to Aphis glycines” (Rag) genes, Rag1, 
Rag2, Rag3/Rag3, and Rag4, are known to function in soybean resistance to soybean 
aphid, although more are likely to be involved [5,10].  Unfortunately, rag genes do not 
provide consistent performance against all soybean aphid biotypes, as certain biotypes 
display a lack of susceptibility to one or more rag genes [5,10].  Natural host plant 
resistance offers a strategy for the management of soybean aphid on soybean, 
particularly in combination with other management approaches. 
Aphid Resistant Transgenic Plants 
While transgenic approaches are not currently in use for suppression of aphid 
populations, several strategies have been investigated to that end. Transgenic plants for 
aphid resistance provide a modern approach to the management of aphids on crops.  
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There are a variety of strategies behind transgenic plants, ranging from the 
heterologous expression of a toxin/resistance gene found elsewhere in nature to the 
expression of “designer” toxins modified specifically to target aphids.   
Plant lectins are naturally occurring carbohydrate-binding proteins associated 
with plant defense against a variety of threats including pathogens and feeding by 
insects [12].  More often than not, plant lectins active against aphids preferentially bind 
to mannose residues present on the gut epithelium, ultimately disrupting gut integrity 
resulting in a variety of effects ranging from reduced feeding to insect death [12,13].  
The heterologous expression of plant lectins has been used with some success to 
manage a variety of aphid species, although this approach has yet to be employed 
against soybean aphid [8].  While the heterologous expression of lectins in plants 
provides a powerful technology to use against a variety of aphids, it is not without 
issues, notably a higher risk for off-target activity, as well as inconsistent field 
performance [8,12]. 
Another viable strategy for the management of aphids is the use of toxins 
modified with enhanced activity towards aphids.  Such toxins may act within the gut 
(e.g. toxins derived from Bacillus thuringiensis, Bt) [14], or within the hemocoel (e.g. 
neurotoxins derived from spider venom, such as Hv1a) [15]. Different strategies exist to 
engineer toxins, but the central theme is the identification of the bottleneck limiting or 
inhibiting activity against the desired target pest and modifying the toxin to reduce the 
impact of said bottleneck.  Common bottlenecks for toxin efficacy against aphids include 
inefficient transcytosis across the gut epithelium for neurotoxins, limited toxin stability 
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in the aphid gut, a lack of binding to the gut epithelium, and limited activation of 
protoxins (e.g. Bt toxins) [16].  By targeting these bottlenecks, several modified toxins 
have been made with activity against a variety of aphid species.   
An insect specific neurotoxin derived from spider venom, ω-hexatoxin-Hv1a 
(Hv1a), with no measurable activity against aphids when ingested, has been fused to 
two different carrier proteins to promote transcytosis across the aphid gut into the 
hemocoel. These toxin-carrier fusion proteins exhibited toxicity against several aphid 
species [17,18].  Fusion of Hv1a to pea enation mosaic virus (PEMV) coat protein 
resulted in toxicity against several aphid species, including pea aphid (Acyrthosiphon 
pisum), soybean aphid (A. glycines), green peach aphid (Myzus persicae), and bird-
cherry oat aphid (Rhopalosiphon padi) [17].  Fusion of the snowdrop lectin (GNA) to 
Hv1a, resulted in toxicity towards green peach aphid and grain aphid (Sitobion avenae).  
While the use of carrier proteins to deliver insect-specific neurotoxins into the aphid 
hemolymph is an exciting avenue for future research, modification of the gut-active Bt 
toxins holds considerable promise, particularly considering that use of modified Bt 
toxins is less emotive than use of toxins derived from spider and scorpion venom.    
 
 
The remainder of this section has been published in a review paper by Deist B, Rausch 
M, Fernandez-Luna M, Adang M, and Bonning B [19].  
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Bacillus thuringiensis Derived Toxins for Pest Management 
The ubiquitous Gram-positive spore-forming bacterium Bacillus thuringiensis (Bt) 
provides a valuable resource due to its ability to synthesize crystal parasporal inclusions 
during sporulation [20]. These crystals, which include insecticidal proteins called δ-
endotoxins have been extensively used as biological insecticides against insect pests of 
commercial interest [20]. More than 175 million hectares were planted to transgenic 
crops expressing Bt toxins in 2013, highlighting the practical importance of these toxins 
for pest suppression [21]. 
Bt crystal toxins include the Cry proteins (crystal toxins) and Cyt proteins 
(cytolytic toxins) [22,23]. While the ETX/MTX-like and the Binary (Bin)-like toxins do 
have Cry designations, they belong to structurally different classes of Cry toxins; we 
refer the reader to an updated review on Cry toxins diversity [23]. The Cry toxins are 
important virulence factors allowing for the development of the bacterium in dead or 
weakened insect larvae. The largest group of Cry toxins has three distinct structural 
domains; the so-called three-domain (3D) Cry toxins provide the primary focus for this 
review. The Cyt toxins have in vitro cytolytic activity, in addition to in vivo activity 
against various insects including mosquitos [24].  Cyt toxins which are active against 
certain Diptera, synergize the toxicity of Cry proteins against mosquitoes and delay the 
expression of resistance to the latter [25].   While most Bt crystal toxins are encoded by 
large plasmids, with expression under the control of sporulation-dependent promoters, 
there are also cryptic Cry toxins that are not expressed [20,26].  The high level of crystal 
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protein expression is controlled by a variety of mechanisms occurring at the 
transcriptional, post-transcriptional, and post-translational levels [24]. 
The evolution of resistance by targeted pests is the main threat to the usefulness 
of Bt toxins. We outline Bt toxin mechanism of action to provide the framework for 
toxin modification to combat resistance, or to broaden host range.  
Insecticidal Bt Proteins 
Mode of Action of Bt Toxins 
The conserved structure of 3D Cry toxins, as well as results from a considerable 
amount of research, supports a conserved mode of Cry toxin action [24,27]. The first 
impact of Cry toxins on the insect is cessation of feeding due to paralysis of the gut and 
mouthparts [28]. In addition to gut paralysis, midgut cells swell leading to an ion 
imbalance and death [28]. The molecular events leading to Cry toxin-mediated insect 
death are controversial [27], but the accepted initial steps are as follows: The Bt Cry and 
Cyt proteins require solubilization in the insect midgut to produce protoxins that are 
typically about 130 kDa, 70 kDa or 27 kDa for Cyt. These in turn are proteolytically 
cleaved at the C-terminus and/or at the N-terminus by midgut proteases, generating the 
activated core toxin. The toxin then crosses the peritrophic matrix and binds to 
receptors in the apical membrane of the midgut cells, with receptor binding being an 
important determinant of toxin specificity. Toxin insertion into the epithelial membrane 
forms ion channels or pores, leading to lysis of the cells, damage to the midgut epithelial 
tissue, and death of the larva (Figure 1a) [27,29,30].   
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Figure 1. (a) Schematic representation of the major steps involved in Cry toxicity and proposed sites for modification to increase 
efficacy and/or broaden toxicity. (b) Examples of insect species successfully targeted by modified toxins [19]. 
8
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Structure of Bt Toxins and Domain Function 
Cry protoxins are typically 130 kDa or 70 kDa proteins [24] with the larger 
protoxins having an additional carboxyl region that is not required for toxicity but that is 
required for crystal formation [22,24]. When these crystal proteins are exposed to the 
alkaline environment of the gut of susceptible larvae, the crystals are solubilized and 
proteolytically processed at the N-terminus and/or the C-terminus by midgut proteases 
to yield the active protease-resistant toxin [22,24]. 
Based on their crystal structures, different Cry toxins (Cry1Aa, Cry1Ac, Cry2Aa, 
Cry3Aa, Cry3Bb, Cry4Aa, Cry4Ba and Cry8Ea1 [22,31,32]) have similar folding patterns 
with three distinct domains [22,24]. Domain I is a seven to eight α-helix bundle 
comprised of amphipathic helices surrounding the central hydrophobic helix α-5. 
Domain I is involved in binding and in pore formation [22,24,33].  Domain II consists of 
three antiparallel ß-sheets with exposed loop regions involved in interaction with 
receptors, while domain III is a ß-sandwich of two antiparallel ß-sheets involved in 
receptor binding and possibly membrane insertion. In contrast, Cyt toxins consist of a 
single domain in which two outer layers of α-helix are wrapped around a ß-sheet 
[24,34]. 
The role of domain I in membrane insertion and pore formation in the midgut 
epithelium of the target insect was suggested by the presence of its long, hydrophobic 
and amphipathic helices [33]. The Umbrella Model proposed by those authors depicts 
the hydrophobic helical hairpin α4 and α5 as inserting into the membrane and initiating 
pore formation, while the rest of domain I flattens out on the membrane surface in an 
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umbrella-like molten globule state. Mutant Cry proteins having altered amino acid 
residues on the putative surface residues of domain I and within the α-helices supported 
the role of domain I in membrane binding, insertion and pore formation [35]. 
Domain II is implicated in protein-receptor interactions through the surface-
exposed loops at the apices of the three ß-sheets. Due to their similarities to 
immunoglobulin antigen-binding sites, the loops of domain II were suggested to 
participate in receptor binding. Site-directed mutagenesis and segment swapping 
analyses provided support for this hypothesis [24,33].  The ß-sandwich structure of 
domain III is also suggested to function in receptor binding; evidence for this role in 
toxin action comes from domain III swap experiments discussed below,  and in the case 
of Cry1Ac, the presence of a ‘pocket’ in domain III that binds N-acetyl galactosamine 
moieties on protein receptors [36,37]. Domain III is also implicated in maintaining the 
structural integrity of the toxin molecule by protecting it from proteolysis within the gut 
of the target organism [22,33].  
The Cyt toxins characterized to date are also protoxins that undergo N- and C-
terminal processing. The predominantly ß-sheet core structure of Cyt2A suggests a 
mechanism of action through a ß-barrel-pore [34].  It contains three strands long 
enough to span the hydrophobic lipid membrane, forming a hydrophobic sheet [34, 38].  
In addition to forming pores, Cyt toxins may exert their effects via a general, detergent-
like perturbation of the membrane [39]; the Cyt toxins were recently reviewed [40,41].  
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Truncated Toxins 
A clear and rational approach to Bt toxin action allowed for improvement of 
toxin efficacy. Through a systematic analysis of Cry toxin deletions, the role of the N- 
and C- terminal domains in crystal formation and in toxin activity against different 
insects has been elucidated. Bt 3D crystal pro-toxins form crystalline inclusions that 
probably provide protection against proteolytic degradation by the host cell or external 
environment. Crystal solubilization in the gut of the target insect is required, however, 
for toxin action. This solubilization step occurs in many cases through a series of 
cleavages of the C-terminal half of the protoxin. The C-terminal half of the protoxin is 
cysteine-rich with disulfide bonds and salt bridges that allow for crystal formation 
[22,33]. 
The truncation of Bt toxins has proven to be a useful option for enhancing Bt 
toxin activity. The goal of this strategy is to circumvent the toxin activation step 
resulting in improved toxicity against target pests.  Toxin truncation also improves 
expression levels in planta and deletion analyses yield important information about the 
molecular biology and mode of action of these toxins. 
Deletion Analyses: Localization of the Toxic Portion of the Protoxin 
Cry protoxins are proteolytically activated to produce the mature active toxin. 
This activation step restricts the spectrum of toxicity of these toxins to insects with 
appropriate gut proteases, with activation of the Bt crystal protein being essential for 
toxin action [28]. Low susceptibility may be due to lack of proper proteolytic activation 
or over-digestion of toxin to inactive peptides, and thus a basic knowledge of the toxic 
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portion is helpful for design of new toxins to control non-susceptible pests. To identify 
the minimal gene fragment that encodes the toxic peptide, deletions at the 5’- or the 3’-
end of the Cry1Ab gene from Bt Berliner 1715   [42]  and  Bt kurstaki HD-1-Dipel  [43] 
and Cry1Ac of Bt kurstaki HD-73 [44] protoxins of ~130 kDa (~60 kDa activated) have 
been made. Analysis of Bt strains expressing the toxin-sized proteins, indicated that the 
N-terminal half of the protoxin is sufficient for toxicity [42-44].  Approximately 400 
amino acids can be removed from the C-terminus of the toxin without significant loss of 
larvicidal activity. Several Cry1A toxins are proteolytically cleaved at residue 28 at the N-
terminus [45], followed by removal of the α-helix upon contact with the brush border 
membrane [46]. Notably, the minimal toxic fragment corresponds to the trypsin-
resistant polypeptide [42,45,47]. The full-length (72 kDa) and truncated (61 kDa) forms 
of Cry11A were expressed in cells of the fall armyworm (Spodoptera frugiperda) and in 
larvae of the cabbage looper (Trichoplusia ni) by using a baculovirus expression vector. 
While the full-length protein was highly toxic to mosquito larvae, the truncated protein 
with a 9.6 kDa deletion at the N-terminus was non-toxic [48]. This result corroborates 
the requirement for most of the N-terminal region either directly or indirectly (i.e. 
required for appropriate folding) for toxicity. 
Crystallographic structural studies [49] were of tremendous value for prediction 
of functions of the various Cry domains. Based on structural predictions, deletion of 42 
amino acid residues from the N-terminus of Cry2A domain I resulted in a 4- to 6-fold 
increase in toxicity against the Egyptian cotton leafworm (Spodoptera littoralis), cotton 
bollworm (Helicoverpa armigera),and the black cutworm (Agrotis ipsilon) [50]. It was 
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speculated that the interaction of the N-terminal hydrophilic helix within the putative 
transmembrane domain I could interfere with toxin insertion into the membrane, which 
is required for toxicity [50]. The carboxy-terminal extensions of many Cry toxins mediate 
formation of bipyramidal crystals that are soluble at high pH under reducing conditions, 
typical of the lepidopteran midgut. Deletion of the Cry15Aa C-terminal sequence 
showed that this sequence is not required for activity against the codling moth (Cydia 
pomonella) [51]. In contrast, bipyramidal crystal formation precluded activity against the 
Colorado potato beetle (Leptinotarsa decemlineata). In this case, activity could be 
rescued by solubilization of the toxin [52].  
Knowledge of the toxic portion of a given toxin is also useful for Cry gene 
shuffling. The Cry1Ia truncated protein lacking the C-terminus was used to generate 
mutated variants, by combining Cry gene shuffling with phage-display [53].  The 
screening of this library for variants that bind brush border membrane vesicles (BBMV) 
of the banana stem borer (Telchin licus licus) and for toxicity, revealed four variants with 
greater activity against this pest compared to the non-toxic wild type Cry1Ia. These 
variants provide promising candidate toxins for the future development of T. l. licus 
resistant transgenic plants. 
The truncated Bt toxin gene without the protoxin C-terminus was used for 
expression of the toxin in the early stages of developing Bt transgenic plants. The Cry1A 
protoxin was toxic to transgenic tobacco plants [54] while the toxin truncated at the C-
terminal proteolytic cleavage site that generates the mature toxin, was non-toxic to the 
plants [54]. The truncated toxin did confer resistance to the tobacco hornworm 
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(Manduca sexta), however. Furthermore, expression levels in transgenic tobacco 
sufficient for insecticidal activity were only achieved with the truncated Cry1A, and not 
with the Cry1A protoxin [55].  
The extensive use of Bt toxins has resulted in field-evolved resistance in some 
insect pests. Toxin modification for greater efficacy against resistant insects has been 
achieved with the genetically modified Cry1AbMod and Cry1AcMod toxins. Compared to 
Cry1Ab and Cry1Ac, both Cry1AbMod and Cry1AcMod lack 56 amino acids at the N-
terminus, including the α-1 helix in domain I. Resistant insects with cadherin gene 
mutations such as pink bollworm (Pectinophora gossypiella) [56] were susceptible to 
Cry1AMod toxins, supporting the conclusion that Cry1AbMOD bypasses the toxin 
oligomerization step induced by binding to cadherin.  Interestingly, these Cry1AMod 
toxins were also toxic to strains of the diamondback moth (Plutella xylostella) and 
European corn borer (Ostrinia nubilalis) which are resistant to the native toxins Cry1Ab 
and Cry1Ac, but in these examples resistance was not linked to mutations in cadherin 
[57]. Recently, Cry1AbMod toxin was reported to counter resistance due to low 
cadherin expression, but not low alkaline phosphatase expression [58].  
Improved Expression of Truncated Toxins 
In addition to enhanced in planta expression of the truncated toxin compared to 
expression of the protoxin, Hayakawa et al. [59] designed a gene encoding the truncated 
Cry4Aa with the GC content and codon preference of E. coli. These modifications 
resulted in significant improvements in expression levels in E. coli, with the recombinant 
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toxin exhibiting the same toxicity against larvae of the common house mosquito (Culex 
pipiens) as the native Cry4Aa. 
Park et al. [60] obtained inclusions of truncated Cry1C (Cry1C-t) by combining 
genetic elements from other endotoxin genes and operons that enhance Cry protein 
synthesis. Increased levels of Cry1C-t synthesis were achieved by using Cyt1A promoters 
to drive expression of the N-terminal half of Cry1C, shown to be toxic to beet armyworm 
larvae (Spodoptera exigua) when expressed in the HD1 isolate of B. thuringiensis subsp. 
kurstaki [60].  
Cleavage Site Modifications 
Processing of the Cry protoxin into its active form is essential for toxin activity.  
Processing is mediated by insect proteases that cleave the protoxin polypeptide at 
specific sequences. Refer to [61] for a detailed review of the role of proteases in Cry 
toxin action.  Processing of protoxins has been best described in the 3D group of Cry 
toxins, with relatively little information available on the processing of Cyt, Vip, and 
binary Cry toxins. Cleavage of the 3D Cry toxins results in the removal of N-terminal 
peptides, and occasionally C-terminal peptides in larger protoxins, producing the active 
toxin (Cry3) or a toxin intermediate (Cry1, Cry4, Cry11).  For the latter, activation is 
completed by proteolysis at additional intramolecular sites to produce the active toxin 
fragments [24,62-64].  Proteolytic cleavage at these sites is required for subsequent 
events involved in toxicity [65-67], and may be exploited in the design and construction 
of modified toxins [67,68].  Proteolytic cleavage that results in toxicity is referred to as 
processing or activation.  This section describes evidence supporting proteolytic 
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cleavage as an activation step in 3D Cry toxins and how this process can be utilized for 
toxin modification.  
Toxicity and Protoxin Processing 
One of the initial observations that suggested proteolytic processing as a toxin 
activation step is that feeding a susceptible insect species on protoxin or on activated 
toxin resulted in similar levels of mortality, and that toxicity could be attenuated when 
protoxin was fed in the presence of protease inhibitors [65-67]. Toxicity can also be 
achieved in a non-susceptible species by feeding with activated toxin [69,70] suggesting 
that inefficient processing of protoxin precludes toxicity. Fragments of activated toxin 
produced by intramolecular cleavage can remain toxic when both fragments are present 
in the gut lumen. For example, Cry4Aa is processed to 45 and 20 kDa fragments from a 
130 kDa protoxin [64]. Yamagiwa et al. [71] produced GST fusions of both the 45 and 20 
kDa fragments.  Neither GST (glutathione S-transferase)-45 nor GST-20 was toxic on its 
own when assayed against Culex pipiens larva. However, the presence of both 
fragments resulted in insecticidal activity [71], indicating that both are needed for 
toxicity.  Activated Cry toxins that exhibit appreciable toxicity against species that lack 
susceptibility to the protoxin could be modified by insertion of sequences recognized by 
the proteases of the target insect to facilitate protoxin activation. The following 
paragraphs discuss the molecular events following processing that may facilitate 
toxicity.  
Toxin binding to insect gut receptors preferentially occurs after appropriate 
proteolytic cleavage.  Greater specific association was noted between processed toxin 
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and brush border membrane vesicles (BBMV) than between protoxin and BBMV [65-
67,72,73].  Carroll et al. [66] found that chymotrypsin treated Cry3A bound specifically 
to L. decemlineata BBMV at the pH of the L. decemlineata gut (pH 7.4). In contrast, the 
Cry3A protoxin did not display specific binding at either the pH found in the insect gut 
(pH 7.4) or at a pH at which the Cry3A protoxin is soluble (pH 10). Trypsin or 
chymotrypsin treatment of Cry3Ba and Cry3Ca also resulted in specific binding to the 
BBMV of L. decemlineata, while the protoxin did not exhibit specific binding [66,72,73]. 
Activated fragments of Cry1Ab following incubation with M. sexta gut juices bound 
BBMV [74].  In ligand blotting experiments, processed Cry4Aa bound BBMV of C. pipiens 
following incubation with gut extracts [74].  These examples demonstrate that 
processing of the protoxin preceeds toxin binding to epithelial cells.  These results 
suggest that following proteolytic cleavage the core toxin is relatively more accessible 
than protoxin for binding to epithelial cells.   
Effects of Activation on Toxin Solubility 
Proteolytic activation of toxins can also enhance solubility.  Toxins with limited 
solubility form precipitates that restrict interaction with the insect gut environment and 
would be expected to have limited toxicity.  Cry protoxin solubility is dependent on pH 
[24,75]. Insect gut pH varies across insect orders; Lepidoptera and Diptera have an 
alkaline gut pH [24,76], and Coleoptera and Hemiptera have a neutral to acidic gut pH 
[66,75,77,78].  Limited toxicity against non-susceptible insect species may result from a 
gut environment that is not conducive to toxin solubilization. However, Cry solubility 
can change upon proteolytic cleavage. For example, Cry3A protoxin is only soluble under 
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acidic (pH<4) and alkaline (pH>10) conditions.  The susceptible insect species L. 
decemlineata has a neutral gut pH, an environment where Cry3A protoxin forms 
insoluble precipitates.  However, Carroll et al. [66] showed that the solubility of Cry3A 
changes upon activation with chymotrypsin, increasing its solubility at neutral pH; both 
Cry3A protoxin and activated toxin exhibit similar toxicity against L. decemlineata. These 
findings suggest that the challenge of toxin insolubility, and the resulting limited toxicity, 
can be resolved in cases where the insect gut environment is not conducive to solubility.  
Activation is Facilitated by Insect Gut Proteases 
The examples cited provide compelling evidence that proteolytic cleavage of Cry 
toxins can be crucial to toxicity. Proper activation of Cry toxins is facilitated by proteases 
present in the insect gut. Among susceptible species in the orders Lepidoptera and 
Diptera, the major gut proteases are of the serine type [24,79], while in Coleoptera the 
major proteases are cysteine and aspartic proteases, although some use cathepsin G 
serine proteases.  Since activation is a crucial step to achieve toxicity, it has been 
suggested that the type and/or abundance of insect proteases is important in 
contributing to toxin specificity. As mentioned earlier, Cry toxicity can be achieved in 
non-target insect species by protoxin activation prior to feeding. Porcar et al. [70] 
demonstrated that a mixture of Cry4A and Cry4B isolated from a recombinant strain of 
Bt subsp. israelensis that was trypsin activated  displayed enhanced toxicity against the 
pea aphid (Acyrthosiphon pisum) relative to non-activated Cry4, suggesting proteolytic 
activation as an important limiting step in Cry toxicity against aphids. The major 
proteases utilized by A. pisum are cysteine proteases of the cathepsin L and cathepsin B 
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type [77] whereas dipteran species susceptible to Cry4A and Cry4B have serine 
proteases [79]. Pea aphids therefore appear to lack the appropriate proteases required 
for, at least, Cry4 toxin activation.   
Insect proteases may also be detrimental to toxicity by degrading or inactivating 
protoxins by cleavage at inappropriate sites. For example, extensive toxin degradation 
of several Cry1A toxins is implicated in the insensitivity of S. exigua. However, when 
toxin and protease inhibitors were fed in combination, a synergistic effect was observed 
against S. exigua larva, which was decreased as inhibitor concentrations were reduced 
[80].  Similarly, increasing the stability of Cry1Fa toxin against larval gut proteases by a 
cadherin fragment, correlated with increased synergy of toxicity to larvae [81]. In 
addition to lacking the appropriate proteases required for toxin activation, non-target 
insects may also harbor toxin degrading proteases [61].  
Examples of insufficient protoxin activation and degradation can also be found in 
cases of field-evolved resistance to Bt toxins. Alterations in protease content and/or 
activity can result in resistance. Cao et al. [82] investigated several stains of H. armigera 
with resistance to Cry1Ac and found cases of up-regulated and down-regulated protease 
activity conferring resistance in strains with low to moderate resistance. Decreased total 
protease activity resulting in insufficient activation of protoxin was found in some 
strains, while increased esterase, GST, and chymotrypsin activity resulting in toxin 
degradation was found in others [82]. These results are supported by in vitro work 
which described a link between insufficient activation of the protoxin and low toxicity 
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[83].  Although protease activity levels were less important in highly resistant strains, 
modulation of enzyme levels may be important in insects under low selection pressure.  
Modification of Cry Protoxin to Facilitate Proteolytic Activation 
Our current understanding of how 1) Cry protoxin processing precedes toxicity, 
2) insect gut proteases mediate this processing, and 3) insect gut proteases play a role in 
determining the specificity of Cry toxins by appropriate proteolytic cleavage, suggests a 
method for broadening the specificity of 3D Cry toxins to include non-target insects as 
well as combating Cry resistance.  Knowledge of the mode of action of the 3D Cry 
proteins and of insect gut physiology can be combined for the engineering of designer 
toxins. Walters et al. [67] demonstrated the feasibility of this approach by achieving 
toxicity with modified Cry3A (mCry3A) against the relatively non-susceptible western 
corn rootworm (Diabrotica virgifera virgifera). A chymotrypsin G cleavage site 
introduced between α-helices 3 and 4 of domain I was cleaved by western corn 
rootworm gut proteases. The introduced cleavage site resulted in enhanced activity and 
the activated mCry3A bound specifically to D.v. virgifera BBMV [67]. Insertion of 
protease recognition sequences at appropriate sites should result in enhanced 
processing of the protoxin to its active form.  Similarly, in cases of toxin degradation, 
toxins can be engineered for removal of deleterious protease sites.  Bah et al. [68] 
created Cry1Aa constructs designed to resist degradation in the spruce budworm 
(Choristoneura fumiferana) by mutating potential trypsin and chymotrypsin sites. These 
modifications resulted in a 2-4 fold increase in toxicity [68]. Understanding of the 
protease type in the gut of the target insect, as well as the stability and solubility of the 
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candidate Cry toxin will be essential for the success of designer toxins. Fortunately the 
Cry gene database is vast, and the structure, stability and solubility of many Cry toxins 
have been categorized. Although Cry3A is the only toxin engineered using modified 
cleavage sites to date, the success of this approach, as well as the toxicity of activated 
toxins against non-susceptible insects suggests that the approach could be more widely 
applied.   
Potential Post Binding Modification  
The focus of this section has been on the processing events that precede Cry 
toxin binding.  However, post binding cleavage could be important for pore formation, a 
process referred to as proteolytic nicking [84,85]. This process adds an additional facet 
to Cry toxin modification by introducing cleavage sites to promote pre-pore structures 
and pore formation after binding. However, it is unclear how important post binding 
cleavage is for toxicity. Pore formation may not be dependent on post binding cleavage, 
and protease activity at the membrane of epithelial cells may inhibit pore formation [86-
88]. Additional research is needed to clarify post binding events to assess the potential 
for Cry modification to stimulate pore formation.     
Binding Modifications 
Proteolytic activation of Bt toxins, and the subsequent binding to the insect gut 
epithelium, are important steps for toxicity (reviewed in [23]).  Modification of either or 
both of these steps for a particular Bt toxin should therefore result in altered host range 
and/or altered toxicity.  Several approaches have been taken to modify the binding 
specificity and affinity of Bt toxins with the ultimate goal of producing designer toxins 
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that target new pest species and counter field evolved resistance. The alteration of Bt 
toxin binding affinity and specificity can be broken down into four categories: domain or 
loop swapping between Cry toxins, site-directed mutagenesis, incorporation of binding 
peptides or fragments from non-Bt toxins, and the generation and subsequent display of 
Cry toxin mutant libraries on phage. 
Domain Swapping 
Domain swapping between Cry toxins is perhaps the oldest method used for 
engineering toxins with novel properties.  These large exchanges can also provide 
information on the function of the exchanged segments.  For example, domain III 
exchanges between Cry toxins have implicated this domain in both toxin binding and 
host specificity [89-92].  For this reason, domain III of three domain Cry toxins is used 
extensively in domain swapping experiments. However, at least one domain II exchange 
has been successful, with movement of domain II of Cry1Ia to Cry1Ba resulting in a toxin 
with strong activity against L. decemlineata [93]. 
Exchanging domain III of the 3D Cry1 toxins between Cry1 toxins has been used 
to enhance toxicity against particular insect pests [89-91,93], and to enhance the 
toxicity of more distantly related 3D Cry toxins [92].  It is often the case that the 
substitution of all or part of domain III from one Bt toxin to another confers the 
specificity of the donor toxin upon the recipient toxin [89-91].  However, there is an 
instance of a domain III exchange from a Cry1A-active toxin altering the binding 
specificity of a coleopteran-active Cry3A toxin. Hybrid Bt toxin, eCry3.1Ab, was 
generated by the incorporation of a large section of the lepidopteran-active domain III 
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of Cry1Ab into the coleopteran-active modified Cry3A (mCry3A) [67,92] and the 
resulting hybrid toxin displayed significant activity (approximately 94% mortality) 
against D. v. virgifera [92]. Interestingly, this is the only documented case of a successful 
domain exchange between more distantly related Cry toxins.   
Although there has been success in using domain swapping as a method for 
modifying Bt toxins for enhanced efficacy, this approach is limited by a lack of 
knowledge of what domain II and domain III contribute to the activity of each toxin 
[89,91].  Until these issues are addressed, the rational design of Bt toxins via domain 
swapping is hampered. 
Site-Directed Mutagenesis 
Site-directed mutagenesis of Cry toxins has resulted in impressive enhancements 
in toxicity against various insect species.  Domain II has been heavily targeted for 
modification as this domain is involved in receptor binding [24].  Modifications have 
been used to enhance toxicity of Bt toxins that already display activity against the target 
insect [94], as well as against non-susceptible insects [95-98].  Loop 1, loop 2, and loop 3 
of domain II are of particular interest because they interact with receptors in the gut of 
the target pest. These loops have been successful targets for alteration, although the 
success of the loop modifications appears to depend on both the toxin and the target 
insect.  Loop 1 of domain II of Cry3A was altered, resulting in mutants displaying 
significant increases in toxicity against L. decemlineata, the yellow mealworm (Tenebrio 
molitor), and the cottonwood leaf beetle (Chrysomela scripta), as well as an increase in 
binding affinity to L. decemlineata BBMV [94].  Modifications to loop 1 and loop 2 of 
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domain II of Cry19Aa made it more Cry4Ba-like: Deletions in loop 2 of domain II and the 
substitution of Cry4Ba loop 1 residues into loop 1 of Cry19Aa resulted in the mutant 
toxin, designated 19AL1L2. This toxin showed a 42,000-fold increase in toxicity to the 
yellow fever mosquito (Aedes aegypti) [97].  In stark contrast, when attempting to 
introduce activity against the southern house mosquito (Culex quinquefasciatus) and C. 
pipiens to Cry4Ba, any modifications to loop 1 or loop 2 of domain II resulted in a loss of 
activity against A. aegypti and common malaria mosquito (Anopheles quadrimaculatus).  
However, activity against C. pipiens and C. quinquefasciatus was successfully introduced 
to Cry4Ba through modifications to loop 3 of domain II [96].  These results support the 
variability of Cry toxin interactions with insect gut receptors based on the particular Cry 
toxin and insect species, an important factor to consider when selecting a toxin to 
modify for activity against a particular pest. A toxin with a basal level of toxicity against 
the target pest is optimal for enhancement by toxin modification. 
Site-directed mutagenesis was used to dramatically shift the specificity of 
Cry1Aa, a lepidopteran-active toxin. This toxin was modified for toxicity against C. 
pipiens.  Cry1Aa did not cause observable mortality in C. pipiens when fed at a 
concentration of 100 μg/ml.  Loop 1 and loop 2 of domain II were modified to mimic 
loop 1 and loop 2 of Cry4Ba in both amino acid sequence and loop length.  The resulting 
mutant toxin lost activity against the lepidopteran M. sexta but gained activity against C. 
pipiens, with an LC50 of 45 μg/ml [98], marking a considerable improvement in toxicity 
against this insect.  This work further supported the importance not only of the amino 
acid residues involved in binding to the receptors, but of the length and shape of the 
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loops.  Loop 1 of Cry1Aa is shorter than that of Cry4Ba, while loop 2 of Cry1Aa is longer 
than loop 2 of Cry4Ba.  When mutant toxins were produced with a longer loop 2, 
mosquitocidal activity was not observed [98].   
Site directed mutagenesis has been used successfully to modify Bt, and offers a 
powerful tool to combat resistance in Bt susceptible pest species, as well as to broaden 
the spectrum of insect pests targeted by Bt toxins.  In addition, this approach has 
provided important insight into the specific Cry toxin residues that interact with insect 
gut receptors.  
Use of Synthetic Peptides and Non-Bt Toxin Regions 
The use of synthetic gut binding peptides and non-Bt toxin fragments in the 
engineering of Bt toxins is a relatively new approach, which has the potential to easily 
enhance the toxicity of Bt toxins against pests which have little to no susceptibility. The 
first example involved the fusion of the non-toxic lectin, ricin B-chain, to the C-terminus 
of lepidopteran-active Cry1Ac via a four amino acid linker region, to produce a toxin 
designated BtRB [99].  BtRB was expressed in rice and maize and subsequently tested 
against the striped stem borer (Chilo suppressalis), cotton leaf worm S. littoralis, and the 
maize leafhopper (Cicadulina mbila).  Mortality was increased against the Cry1Ac 
susceptible C. suppressalis, from approximately 17% to 75% on maize and from 20-30% 
to 60-90% on rice.  BtRB substantially increased the mortality of Cry1Ac-tolerant S. 
littoralis, from less than 20% on control maize plants to 78% on BtRB-expressing maize 
plants at 4 days.  The mortality of C. mbila fed on control maize plants was about 20%, 
while the mortality on BtRB-expressing maize plants was about 95%.  Although the ricin 
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B-chain did enhance the activity of Cry1Ac, it did not do so indiscriminately as neither 
Cry1Ac nor BtRB displayed activity against the bird cherry-oat aphid (Rhopalosiphum 
padi) [99].  This result may reflect the specificity of ricin B binding to galactose residues 
and the abundance of these residues in the insect gut, however as discussed above, a 
number of other factors affect Cry host range. The introduction of toxicity to a Bt toxin 
against a hemipteran, C. mbila, was significant however, as few Bt toxins display toxicity 
against hemipteran pests [70,100,101].  In a similar study, replacing domain III of Cry1Ac 
with Allium sativum agglutinin (ASAL; a mannose-binding lectin) resulted in a 30-fold 
increase in toxicity against H. armigera and an 8-fold increase against P. gossypiella, as 
well as an expanded binding profile to H. armigera BBMV in a ligand blot [102].   
Through the addition of lectins to Cry1Ac, toxicity against susceptible and non-
susceptible insect pests was enhanced, albeit in an unpredictable manner.  The 
incorporation of short gut binding peptides, identified via a phage display library, into Bt 
toxins provides a method to target specific pests that lack susceptibility to Bt toxins.  To 
date, two papers have been published on the use of receptor binding peptides to modify 
Bt toxins.   
A 12-aa A. pisum gut binding peptide, designated GBP3.1, previously identified 
by feeding A. pisum on a phage display library [103] and subsequently found to bind to 
A. pisum alanyl aminopeptidase-N (APN), was incorporated into different loops of the 
cytolytic Bt toxin Cyt2Aa through the addition or substitution of amino acids [104].  The 
incorporation of GBP3.1 into loops 1, 3 and 4 of Cyt2Aa resulted in mutants with 
significantly higher binding to A. pisum BBMV, as measured by pull-down assays and 
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surface plasmon resonance. The increase in binding was accompanied by a significant 
improvement in toxicity to A. pisum, lowering the LC50 from > 150 μg/ml to 10-29 μg/ml.  
The mutant Cyt2Aa toxins also displayed improved activity against the green peach 
aphid (Myzus persicae), lowering the LC50 from >150 μg/ml to 4393 μg/ml [104].   
Interestingly, while GBP3.1 bound to APN, a glycosylphosphatidyl inositol (GPI)-
anchored membrane bound protein that has been implicated as a receptor for Bt toxins, 
in the case of Cyt and possibly the 3D Cry toxins, the specific protein which binds the 
toxin may not matter.   
The ‘sequential binding model’ of 3D Cry toxin-receptor interactions, where Cry 
toxins interact with a number of insect midgut proteins that facilitate formation of 
oligomeric structures and membrane insertion [105], supports the concept that 
receptor identity may not be as fundamental as once thought.  For example, the highly 
toxic Cry11Ba toxin binds at least four different GPI-anchored proteins (alkaline 
phosphatase, aminopeptidase, and two glucosidases), plus two cadherin-like proteins in 
the midgut of the malarial mosquito Anopheles gambiae [106,107]. It may be 
advantageous from the perspective of insecticidal potency to have multiple midgut 
binding proteins acting as ‘accessory’ receptors to gather toxin at the midgut brush 
border protein level. The concept of increasing toxin retention leading to increased 
potency is suggested by the following example: an Asian longhorn beetle (Anoplophora 
glabripennis Motschulsky) Cx-cellulase binding peptide, designated PCx, was used to 
modify Cry3Aa.  PCx was fused to either the N-terminus (PCx-Cry3Aa) or C-terminus 
(Cry3Aa-PCx) of Cry3Aa.  PCx-Cry3Aa and Cry3Aa-PCx both showed increased toxicity 
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against the Mulberry longhorn beetle (Apriona germari Hope), roughly doubling the 
mortality of A. germari compared to Cry3Aa.  In addition the retention of PCx-Cry3Aa in 
the midgut of A. germari was significantly increased relative to Cry3Aa [108]. This 
approach suggests that increasing the ‘bindability’ of Cry toxins may augment 
recognized Bt toxin receptors such as cadherin, APN, and ALP. Alternatively, increased 
retention of Bt toxin in the insect gut, as well as proximity to the gut epithelium, may in 
itself be sufficient for increasing toxicity and target range.   
Phage Display  
A phage display library expresses a diverse array of peptides or proteins on the 
surface of bacteriophage. Peptides or proteins that have a higher target binding affinity 
are selected by screening the phage display library against purified receptor or BBMV 
immobilized on a substrate [53,109-111]. Alternatively, feeding assays can be used to 
isolate peptides or proteins that bind to the gut epithelium of a targeted insect [103].  
Unbound phage are removed by washing.  Bound phage are then eluted and amplified 
in E. coli for subsequent rounds of selection, and selected phage sequenced to identify 
sequences encoding peptides of interest. 
Phage display libraries expressing mutant Cry toxins offer a potentially powerful 
method for engineering Cry toxins.  The most important aspect of this methodology is 
the successful display of complete Cry toxins on the surface of a phage, followed by the 
generation of phage display libraries expressing mutant Cry toxins and the subsequent 
selection of mutant Cry toxins via binding affinity to BBMVs or purified gut receptors. 
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The display of Cry toxins on the surface of phage has been attempted several 
times over the past twenty years, with initial attempts resulting only in partial success.  
The earliest published attempt to display a Cry toxin on a phage succeeded in only 
displaying domain II or only loop 2 of domain II of Cry1Aa on M13 phage, despite 
attempts to display the activated toxin.  In this case, the E. coli were unable to produce 
the activated toxin, possibly due to Cry1Aa being directly or indirectly toxic to the cells 
[112].  Despite not displaying activated Cry1Aa, the successful display of domain II and 
loop 2 of domain II still allowed for the generation of combinatorial libraries that could 
be used to identify sequences with higher binding, and thus potentially enhanced 
toxicity, once incorporated into the complete toxin. This goal could also be 
accomplished by incorporating short binding peptide sequences identified via phage 
display library into any number of Bt toxins [103-108].  A concurrent attempt to display 
Cry1Ac on the surface of a phage was more successful in that Cry1Ac was displayed, and 
was active against M. sexta and H. virescens.  However, when exposed to BBMV, Cry1Ac 
was cleaved from the phage, limiting in vivo and in vitro applications [113]. 
Recent efforts with phage display of Bt toxins have been more successful. Cry1Ac 
was successfully displayed on λ phage by fusing the toxin to the structural D protein, an 
essential protein for phage stability found in the head of λ phage. The fusion protein 
successfully bound to brush border membrane proteins, purified from a preparation of 
M. sexta BBMV.  However, the display of Cry1Ac on λ phage did result in a 20-fold 
decrease in toxicity against M. sexta [114].  The decrease in toxicity may have resulted 
from the λ phage inhibiting secondary binding events or pore formation.  Fusion of 
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Cry1Ac to the T7 phage structural gene 10B provided comparable mortality in M. sexta 
to Cry1Ac [115].  Despite the decreased toxicity seen in some instances, the successful 
display of Cry1Ac on the surface of λ phage and interaction of the displayed toxin with 
gut receptors is a significant step forward for use of phage display libraries for selection 
of toxins with enhanced binding properties. The screening of libraries displaying 
complete toxins under in vivo conditions is less practical, as toxins with increased 
binding are expected to damage the gut epithelium or kill the insect, thereby hampering 
isolation of bound phage for further enrichment.  
There have been a few attempts to generate and screen Cry mutant libraries for 
enhanced binding and toxicity via phage display [53,109-111].  Two of these attempts 
involved the generation of domain II mutant libraries [109,111], while the other two 
mutant libraries were generated by introducing mutations into random locations in Cry 
genes [53,110].  However, a noted difficulty with this approach is generation of inclusive 
mutant libraries [111]. This problem could be alleviated by targeting shorter amino acid 
sequences for mutation [109], decreasing the number of possible permutations of the 
target sequence, thereby decreasing the number of mutants needed for an inclusive 
library.  As stated previously, an important consideration is the probable difficulty of in 
vivo biopanning, as toxin-induced mortality could hamper elution of bound phage from 
the insect gut.  This limitation restricts library screening to the use of purified receptors 
[109,111], or BBMV [35,92], which do not necessarily represent biologically relevant 
conditions, and could lead to the selection of toxins that are not active under in vivo 
conditions.   
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The generation of mutant Cry toxin libraries and their display on various phage 
provides a powerful approach for the selection of toxins with enhanced efficacy against 
target insect pests, but with important limitations.  Production of a representative 
mutant library, particularly when altering specific regions of a Cry toxin, is an important 
but technically limiting step. Phage display library screens conducted in vitro may not 
result in toxins active under in vivo conditions.  
Concluding Remarks 
Toxins derived from the bacterium B. thuringiensis have been used extensively to 
manage insect pest populations, traditionally through foliar sprays and more recently 
via transgenic crops.  A thorough understanding of the mode of action of these toxins is 
required for full exploitation of their potential.  Some insects of agricultural and human 
health importance lack susceptibility to Cry toxins while other species evolve resistance 
in response to intense selection pressure. The lack of toxicity in these cases likely 
involves interference with crucial steps in toxin action: N- or C-terminal cleavage, 
intramolecular proteolytic cleavage, and / or binding to the insect gut epithelium (Fig 
1a). Based on understanding of Cry toxin mode of action and the gut physiology of 
targeted pests, specific modifications have been made to counter these limitations to 
toxicity.  Toxin modification has resulted in toxins with increased efficacy against various 
target pests, and increased understanding of toxin mode of action.  Incorporation of 
such modified toxins into current management strategies will maximize the use of Bt as 
a tool for crop protection and for management of insect borne disease.   
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Research Problem 
 Of the Bt-derived toxins that have been tested for efficacy against aphids, we 
selected the 3-domain toxin, Cry4Aa, for genetic enhancement on the basis that low-
level toxicity has been recorded [70].  A lack of binding to soybean aphid gut is a 
potentially important bottleneck in the low toxicity of Cry4Aa against soybean aphid.  To 
improve toxicity of Cry4Aa against soybean aphid, we isolated and incorporated a 
soybean aphid gut binding peptide into Cry4Aa, to provide for increased binding to the 
target gut epithelium cells. Increased toxin binding to the soybean aphid gut epithelium 
is expected to result in increased toxicity against this pest.  
Thesis Organization 
 In Chapter 2, we report on the isolation and use of the soybean aphid gut 
binding peptide, SG3, in the modification of Cry4Aa for enhanced binding to the 
soybean aphid gut.  Significant findings from this work and potential future research 
directions are discussed in Chapter 3. 
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Abstract 
Soybean aphid poses a significant threat to soybean agriculture in North 
America.  Current management strategies are heavily dependent on chemical 
insecticides, which while presently effective, may have negative side effects.  Bt toxins 
have been successfully used in various transgenic crops for almost 20 years to manage 
lepidopteran and coleopteran pests.  However, this strategy has not been used in the 
management of aphids and other hemipterans due to their low susceptibility to Bt 
toxins, potentially arising from a lack of binding to the hemipteran gut.  To circumvent 
this limitation in soybean aphids, a phage display library was screened in vivo against 
the soybean aphid gut to identify candidate gut-binding peptides to add to a Bt toxin.  
The in vitro binding capacity of candidate gut-binding peptides was characterized.  The 
candidate with the strongest gut binding was used to engineer the Bt toxin Cry4Aa by 
insertion of the peptide sequence at seven sites in the toxin: N-terminal region (three 
sites), loop 2 and loop 3 of domain II, and the loops formed between β12-β13 and β15-
β16 of domain III.  Four of the seven engineered toxins maintained stability upon 
activation and native toxicity against Culex pipiens larvae.  The four remaining toxins are 
currently being tested against soybean aphid. 
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Introduction 
 Soybean aphid (Aphis glycines Matsumura) is the foremost pest of soybean 
(Glycines max) in North America.  Since the first identification of the soybean aphid in 
North America in 2000, soybean aphid has been identified in 30 U.S. states and 3 
Canadian provinces [1].  The soybean aphid can cause up to 40% yield loss via feeding, 
the transmission of plant viruses, and promotion of the growth of sooty mold on the 
surface of the soybean [1–3]. 
 Current management practices for soybean aphid rely heavily on the use of 
chemical insecticides, [1,4,5].  However, should resistance to chemical insecticides 
develop, rapid population growth allows soybean aphid to quickly spread resistance, 
making the development of alternative management strategies imperative [1,4,5].   
 Bacillus thuringiensis (Bt) is a soil-dwelling pathogen of invertebrates [6,7].  Bt 
produces a wide array of toxins, most notably the Crystal (Cry) family of toxins.  Specific 
Cry toxins display toxicity against lepidopteran, coleopteran, and / or dipteran insects, 
and kill by disrupting gut integrity via a complex and incompletely understood mode of 
action [8].  The established steps in the mode of action of Cry toxins are: Solubilization 
in the insect gut, activation, binding to gut receptors, membrane insertion, and pore 
formation leading to osmotic lysis [8–10].   
 Cry toxins have been expressed in transgenic crops for the management of 
coleopteran and lepidopteran pests for close to twenty years [2].   The success of Cry 
toxins partially stems from their high degree of specificity, in general Cry toxins are 
primarily active against lepidopterans, coleopterans, and dipterans [8].  Some 
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hemipteran species, including aphids, have limited susceptibility to Cry toxins [11–14].  
Low toxicity of Cry toxins against aphid species can be be explained in some cases by 
inefficient toxin activation, and / or a lack of Cry toxin binding in the aphid gut [11,15].  
Cry toxin engineering can be used to enhance toxicity of Cry toxins with limited activity 
against a particular species by targeting bottlenecks to toxicity [16]. 
 Cry4Aa is a 3-domain Cry toxin that displays a low level of toxicity against the pea 
aphid (Acythrosiphon pisum), making it an ideal candidate for modification to enhance 
toxicity against not only pea aphid, but other aphid species such as soybean aphid 
[11,17].  Bt toxins, primarily Cry toxins, have been engineered for enhanced activity 
against novel insect targets, largely through increased processing and increased binding 
of toxins to the insect gut [16].  Here, we modified Cry4Aa to enhance toxicity against 
the soybean aphid via the addition of a soybean aphid gut binding peptide. In separate 
modified toxins, the peptide was added to each of five sites within exposed loops or at 
the N-terminus of the protein.  By incorporating a soybean aphid gut-binding peptide 
our goal was to increase binding to the gut for enhanced toxicity against the soybean 
aphid. 
Materials and Methods 
Soybean Aphid Rearing 
Soybean aphids were field collected from Iowa.  Soybean aphids were reared in a 
growth chamber on Williams 82 soybean, (Glycines max) (Continuous light, 22°C, 70% 
RH). 
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Expression and Purification of Soybean Aphid Alkaline Phosphatase 2 and 
Aminopeptidase N3 
 
We used two approaches for isolation of peptides that bound to the soybean 
aphid gut. The first approach was to PCR-amplify cDNA for the abundant, membrane-
associated proteins alkaline phosphatase 2 (ALP2) and aminopeptidase N3 (APN3) for 
expression in insect cells using a recombinant baculovirus expression vector. These 
sequences were identified from the soybean aphid gut transcriptome [18], PCR 
amplified and cloned into pFastBac™ (Invitrogen™ by Life technologies™) using standard 
procedures. Sf21 cells (Invitrogen™ by Life technologies™) in T75 flasks were infected 
with ALP2 or APN3 baculovirus at an MOI of 5 and cells were incubated at 28oC. Cell 
culture medium was harvested 96 hours post infection, centrifuged at 3,000g for 10 
minutes [19] and recombinant protein expression assessed by SDS-PAGE (12%). 
Recombinant, 6X His-tagged, APN was purified by affinity chromatography, using 
a TALON agarose (Clontech) column equilibrated with 50 mM NaH2PO4, 100 mM NaCl 
pH 8.0 (Buffer A) and washed with 10 volumes of Buffer A containing 5 mM Imidazole. 
Protein was eluted with 1.5 ml Buffer A containing 10 mM imidazole. The collected 
fractions were analyzed by SDS-PAGE (12%), enzymatic activity [19] and the APN-
containing fractions were dialyzed.  
Recombinant, 6X His-tagged, ALP was purified by anionic exchange 
chromatography using a Sepharose Q Fast flow column (GE) equilibrated with 20 mM 
Tris-HCl pH 8.5, 1 mM MgCl2.  Anionic exchange chromotagraphy was used instead of 
affinity chromatography due to inadequate purification by use of the TALON agarose 
column.  Protein was eluted with a NaCl gradient (0.5 – 1 M). The collected fractions 
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were analyzed by SDS-PAGE and enzymatic activity [19]. ALP-containing fractions were 
dialyzed. For both recombinant proteins,  concentration was quantified by Bradford 
assay with BSA standards [20]. 
Screen for Peptides that Bind ALP and APN  
Peptides were selected from the Ph.D-C7C phage display library.  The library is 
comprised  of peptides displayed on the surface of the M13 phage.  The peptides consist 
of a seven amino acid variable region flanked by cysteine residues to form a disulphide 
bridge, resulting in the seven amino acid variable region configured in a loop.  The Ph.D.-
C7C library (New England Biolabs; 1010 PFU) was diluted 100 fold in 100 uL of 50 mM 
Tris-HCl, 150 mM NaCl, pH 7.5 (TBS buffer) and 0.1% Tween. Three cycles of biopanning 
were performed as follows: polystyrene microtiter wells were coated with ALP or APN 
(10µg/ml in TBS Buffer – 0.1% Tween) overnight on a rocking platform at 4°C. Excess 
binding sites were blocked with 0.1M NaHCO3 (pH 8.6), 5mg BSA at 4°C for 1h. After 6 
washes with TBS –Tween 0.1%, the phage library was added. The library was incubated 
1 hour at room temperature on a rocking platform. Unbound phages were removed by 
10 washes with TBS – Tween 0.1%. The binding interactions with the phages were 
disrupted with 0.2M Glycine –HCl (pH 2.2), and 1 mg/ml BSA for 20 minutes, and the 
reaction was neutralized with 1M Tris-HCl (pH 9.1). An aliquot of the eluate was titered 
and the remaining eluate was amplified in Escherichia coli for subsequent rounds of 
biopanning. A total of three rounds of biopanning were performed with TBS with 0.5% 
Tween. After the third round, peptide sequences encoded by selected phages were 
determined from 20 plaques. These peptide sequences were compared to the 
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sequences of peptides selected for binding under in vivo conditions (as described 
below), but the peptides were not used for further experimentation. 
Selection of Soybean Aphid Gut-Binding Peptides 
The second approach for isolation of peptides that bind the soybean aphid gut 
was to screen the same phage display for in vivo binding to the gut. Soybean aphid Gut 
binding (SG) peptides were identified from the Ph.D.-C7C phage display library (New 
England Biolabs) following a previously described in vivo selection protocol [21].  After 
the third round of enrichment for gut binding peptides, the peptide sequences of 27 
phages were determined by sequencing phage DNA. 
Construction of Gut Binding SG-GFP Fusions 
For further characterization of peptide binding to the soybean aphid gut, 
constructs for expression of soybean aphid gut binding SG-GFP fusions were generated 
using PCR.  The nucleotide sequence of each SG peptide was incorporated at the 5’ end 
of the forward primer for GFP (5’-GCTGTGAGCAAGGGCGAGG-3’).  Each unique forward 
primer was paired with the reverse GFP primer                                                                     
(5’-CCGAAGCTTTTAGCCGCTTTACTTGTACAGCTCG-3’).    The SG peptides were connected 
to GFP via a three glycine linker region, which was used to maintain peptide 
conformation.   
A linker control, comprised of three glycines attached to GFP, was synthesized.  
Platinum®Taq (Invitrogen™ by Life technologies™) was used to make each fusion 
construct.  The size of each SG-GFP fusion construct was checked via agarose gel 
electrophoresis and ethidium bromide staining.  Bands of the expected size were 
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excised and the DNA purified using a QIAquick gel extraction kit (Qiagen, Venlo, 
Limburg, Netherlands).   
SG-GFP fusions were cloned into pBAD-HisB using XhoI and HindIII restriction 
sites, and subsequently transformed into Top10 Z-competent E. coli cells.  Expression of 
SG-GFP fusions was induced in 500 ml LB cultures with 0.02% arabinose.  The induction 
was allowed to continue overnight at 20°C and shaking at 220 rpm.  After induction, the 
cultures were centrifuged at 3,000 rpm and the pellets stored at -80°C until purification.  
SG-GFP fusion proteins were purified using nickel affinity purification.  Purified SG-GFP 
proteins were assessed by SDS-PAGE and purified protein was quantified via Bradford 
assay [20]. 
Preparation of Soybean Aphid Brush Border Membrane Vesicles (BBMV) 
 
Soybean aphid brush border membrane vesicles were prepared following a 
standardized protocol.  Differential precipitation was used to prepare BBMV from 1 
gram of whole soybean aphids [22].  The enrichment of BBMV was quantified using an 
aminopeptidase N (APN) activity assay to assess enrichment of membrane proteins from 
an early homogenate to the final BBMV.   BBMV sample protein content was quantified 
using a Bradford assay [20].  Protease inhibitor cocktail (Sigma; P8340) was added 
before BBMV samples were stored at -80°C. 
Relative Binding of Soybean Aphid Gut Binding Peptides 
 The relative binding of gut binding peptides to BBMV was assessed by pull-down 
assay at room temperature as described previously [23].  Binding conditions were: PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4), pH 7.4, 1% BSA, and 1% 
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Tween20. Pull-down assays were conducted in duplicate.  An ANOVA was performed to 
identify significant differences in binding based on ImageJ quantification of SG-GFP 
fusions pulled down with BBMV.  Based on the results, the peptide SG3, which was 
among the peptides that bound the most strongly, was selected for further analysis.  
Predictive Modeling of Modified Cry4Aa-S1 
Four exterior loops, as well as the N-terminus, were identified as potential sites 
for addition of the gut binding peptide, SG3. Predictive modeling of modified toxins with 
the peptide sequence incorporated at different sites on each loop was performed using 
Local Meta-Threading-Server (LOMETS) [24].  The amino acid sequences of modified 
Cry4Aa-S1’s were submitted to LOMETS and the resulting models were visualized using 
PyMol (The PyMOL Molecular Graphics System, Version 1.7.4 Schrödinger, LLC.) 
Particular attention was paid to whether the models predicted exposure of the peptide 
sequence on the outside of the toxin molecule, rather than the peptide sequence 
folding inward. Specific sites for insertion of the gut binding peptide were selected 
based on these predictive models.  
Modification of Cry4Aa-S1 
Optimized for expression in E. coli, Cry4Aa-S1 shares the same amino acid 
sequence as Cry4Aa but differs in nucleotide sequence; in addition Cry4Aa-S1 has a 
partial C-terminal truncation [25].  The soybean aphid gut binding peptide SG3, including 
the terminal cysteines, was added to seven separate sites in Cry4Aa-S1 via overlap 
extension PCR (OE-PCR). The sites were: at the N-terminus (three separate sites), loop 2 
and loop 3 of domain II, and the loops formed between β12 and β13 and between β15 
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and β16 of domain III [26]. One addition was made at the N-terminus of the N-terminal 
peptide, one was made at the N-terminus of the activated toxin, and the final addition 
was made two amino acids (six nucleotides) in from the N-terminal peptide cleavage 
site.  See Table 1 for the primers used.  Platinum®Taq Hi-Fidelity (Invitrogen™ by Life 
technologies™) DNA polymerase was used in the modification of Cry4Aa-S1.  Genes 
encoding modified toxins, as well as wild-type Cry4Aa-S1, were visualized using agarose 
gel electrophoresis with ethidium bromide staining.  Bands of the appropriate size were 
excised and the DNA purified using a Qiaquick gel extraction kit (Qiagen, Venlo, Limburg, 
Netherlands) following the provided protocol.  Wild-type Cry4Aa-S1 and the modified 
toxins were cloned into pGEX-2T using the BamHI and EcoRI restriction sites.  Plasmid 
constructs were then transformed into BL21 Z-competent E. coli. 
Expression and Purification of Toxins 
 
Expression of toxins, including the wild type Cry4Aa-S1, was carried out using a 
standardized protocol.  Overnight LB cultures (5 ml) were used to inoculate 500 ml 
cultures of Terrific Broth grown in 2000 ml baffled Erlenmeyer flasks.  The cultures were 
grown at 37°C with shaking at 240 rpm until the appropriate OD600 was reached.  Once 
the OD600 was reached, expression was induced with 0.06 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG).  Cultures were allowed to induce in darkness at 20°C for 5 
hours at 220 rpm.  After induction, cultures were centrifuged at 3000 rpm for 20 
minutes and the cell pellet was stored at -80°C.  Toxins were purified using Glutathione 
Sepharose® (GSH) 4B beads (GE Healthcare Biosciences AB, Uppsala, Sweden).  Toxins 
were eluted from the beads with 50 units of thrombin.  The thrombin was allowed to  
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Table 1.  Primer pairings to make modified Cry4Aa-S1.  Bolded regions denote SG3 nucleotide sequence. 
Toxin Forward Primer (F) Reverse Primer (R) 
Cr4N1 5’ATAGGATCCTGTATGGGGCATACTTTGGGGAGGTGCATGAACCCGTATCAAAAT3’ 5’TATGAATTCTCACACGGTTTC3’ 
CR4N2 5’TGTATGGGGCATACTTTGGGGAGGTGCGGTGAACTGTCGGCA3’ 5’GCACCTCCCCAAAGTATGCCCCATACATGAATCGATGAACGTTTC3’ 
Cr4N3 5’TGTATGGGGCATACTTTGGGGAGGTGCTCGGCATACACCATC3’ 5’GCACCTCCCCAAAGTATGCCCCATACACAGTTCACCTGAATCGA3’ 
Cr4L2 5’TGTATGGGGCATACTTTGGGGAGGTGCTCGCTGGACAACAAA3’ 5’GCACCTCCCCAAAGTATGCCCCATACAGATAACGTTCAGCAGAA3’ 
Cr4L3 5’TGTATGGGGCATACTTTGGGGAGGTGCACCCAGGTGTACACG3’ 5’GCACCTCCCCAAAGTATGCCCCATACATTTGTACGTTGCCGG3’ 
Cr4B12 5’TGTATGGGGCATACTTTGGGGAGGTGCTATACC CAC CTGACC3’ 5’GCACCTCCCCAAAGTATGCCCCATACAGATCGTGTTTTTCGG3’ 
Cr4B15 5’TGTATGGGGCATACTTTGGGGAGGTGCCAGCAATCGTACTTCAT3’ 5’GCACCTCCCCAAAGTATGCCCCATACAAAAATTTGAGTGCTGGC3’ 
Cry4Aa 5'ATAGGATCCATGAACCCG3’ 5’TATGAATTCTCACACGGTTTC3’ 
5
4
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incubate with the beads overnight at 4°C, followed by a 2 hour incubation at 20°C.  Five 
500 μl fractions were collected after trypsin incubation.  Fractions, along with samples 
of the cell lysate and flow through were checked using SDS-PAGE with 12% 
polyacrylamide gels.   The buffer was exchanged to 10 mM Tris-HCl pH 7.5 using Amicon 
Ultra-0.5 Centrifugal Filter Devices with a 3-kDa cutoff (Merck Millipore Ltd., Co Cork, 
IRL).  Toxin concentration was quantified via Bradford assay [20]. 
Structural Stability of Toxins 
To assess the stability of the modified toxins, each toxin was activated using a 
trypsin digest.  A 5% trypsin (w/w) digest was performed on 5 ug of each toxin.  The 
reactions were carried out in 20 ul of 50mM Tris-HCl buffer.  Reactions were incubated 
at 37°C for one hour.  After incubation, 4 ul of 4X SDS-Loading dye was added to each 
reaction and samples were then heated for 8 minutes at 100°C.  Samples were run on 
12% SDS-polyacrylamide gels.  Gels were stained in Coomassie blue R250, destained, 
and scanned using a tabletop scanner. 
Bioassay with Mosquito Larvae 
To assess whether the modified toxins retained their native toxicity, bioassays 
were conducted with mosquito larvae, which are susceptible to Cry4Aa. Bioassays were 
conducted using two-day-old Culex pipiens.  Wild-type Cry4Aa-S1, and modified Cry4Aa-
S1 were used as treatments.  It is important to note that while mosquito larval bioassays 
are normally performed using Cry toxin crystal, Cry4Aa-S1 does not form crystals.  
Assays were conducted using a 24 well plate (Corning Incorporated, Corning, New York), 
with six C. pipiens larvae per well, with three wells per treatment.  Each well contained a 
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final volume of 1-ml toxin in ddH2O. Up to six different concentrations were used per 
treatment (31.25 ng/ml - 2μg/ml).  The concentration ranges were selected based on 
published Cry4Aa LC50 data for C. pipiens larvae, which are highly variable [27].   In 
addition to toxin treatments, each assay had a water only control. Mortality was scored 
every 24 hours for a period of 3 days. Each toxin was categorized as “toxic” or “non-
toxic” to C. pipiens larvae based on bioassay data.  
Soybean Aphid Bioassays 
To assess whether the modified toxins had increased efficacy against soybean 
aphids, bioassays were conducted using 3rd instar soybean aphids.  Native and modified 
toxins were used to spike complete aphid diet [28] with several concentrations ranging 
from 31.25 μg/ml to 500 μg/ml .  Two diet controls were used.  The first control was 2X 
complete aphid diet diluted to 1X with 10 mM Tris-HCl pH 7.5, controlling for both diet 
quality and toxic effect of the buffer.  The second control was 500 μg/ml of BSA in 
complete aphid diet, controlling for any potential toxic effect of high protein 
concentration. 
 A 3 cm petri plate with a 1 cm hole in the lid was used for the bioassays.  Each 
complete aphid diet treatment (100 μl) was placed on Parafilm® stretched thinly over 
the hole in the lid.  Another piece of stretched Parafilm® was placed on top to sandwich 
the droplet of diet over the hole in the lid.  Each plate had 15 soybean aphids, and each 
treatment had 3 plates.  Bioassays were performed under the following rearing 
conditions: continuous light, 22°C, 70% RH. Mortality was scored every 24 hours for 3 
days.  Statistically significant differences were assessed using a one-way ANOVA. 
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Results 
Selection of Binding Peptides 
 Eight candidate Soybean aphid Gut binding peptides (SG) were identified from 
the Ph.D.-C7C phage display library.  Eight candidate peptides were selected for further 
analysis from the 15 unique sequences identified from the third round of biopanning. 
SG1 and SG2 were represented four times, SG3 was represented twice, and SG4, SG5,  
SG6, SG7, and SG8 were represented once each (Table 2).    
Screening of the phage display library Ph.D-C7C against purified soybean aphid 
APN3 and ALP2 yielded twelve and seven candidate binding peptides, respectively.    
Several peptides selected for binding to APN3 (ABP) showed a distinct similarity to 
several SG peptides.  ABP5 and SG6 share four amino acids, ABP11 and SG3 also share  
four amino acids, while ABP7 and SG8, and ABP10 and SG7, each have 3 amino acids in 
common (Table 2).  Many of the common amino acids are also found in similar 
positions.  This level of similarity was not observed between peptides selected for 
binding to ALP2 (PBP) and SG peptides. These results suggest that the peptides SG3, 6, 7 
and 8 bind to aminopeptidase N in the soybean aphid gut. 
Relative Binding of Soybean Aphid Gut Binding Peptides 
 SG-GFP fusions were successfully purified from E. coli (Figure 1).  Assessment of 
the in vitro binding capability of the SG-GFP fusions to whole soybean aphid BBMV via 
pull-down assays revealed two strong candidates for use in modifying Cry4Aa-S1 (Figure 
2).  One-way ANOVA with a post-hoc Tukey’s test (p<0.05) indicated that SG3-GFP and 
SG8-GFP consistently performed the best in pull-down assays.  Interestingly, SG1-GFP  
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Table 2. Comparison among SG peptides and a comparison between SG 
peptides and ABP peptides.  Bold amino acids are shared.  There were no 
common amino acid motifs between SG and PBP peptides.  Common amino 
acid motifs between SG and ABP peptides suggest that some SG peptides 
bind APN. 
Comparison of SG peptides Comparison of SG and ABP peptides 
Peptide Amino Acid Sequence Peptide Amino Acid Sequence 
SG1 TPDSNTE SG3 MGHTLGR 
SG2 SISSLTH ABP11 MGAEILR 
SG3 MGHTLGR SG7 DFPSRGQ 
SG4 LKNSYKI ABP10 MANSRIG 
SG5 CLFTTQPS SG8 STWGRYD 
SG6 LKNQSDQ ABP7 ENKHTWG 
SG7 DFPSRGQ   
SG8 STWGRYD   
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Figure 1. Expression of SG-GFP fusion proteins.  Fusion proteins were purified from E. 
coli cell lysate via nickel affinity chromatography and purity was assessed using SDS-
PAGE.  SGn-GFP fusions run at 37 kDa.  The image is representative of the expression of 
all SGn-GFP fusions. 
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Figure 2.  SG3-GFP and SG8-GFP bind soybean aphid BBMV more strongly than the other candidate peptides. Peptide-GFP fusions 
bound to the BBMV were detected via western blot with anti-GFP antisera.  Bands (seen along the bottom of the figure) were 
analyzed in ImageJ to assess relative amounts of peptide-GFP bound.  Data shown represent two replicate experiments.  Values 
obtained were normalized to 1 by setting the values obtained for SG8-GFP to 1 and adjusting the values for other peptide-GFP 
fusions accordingly.  Statistical differences were assessed with a one-way ANOVA performed on data from two replicates. 
6
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and SG2-GFP, despite being selected for in vivo gut binding, did not bind to BBMV in 
pull-down assays possibly as a result of differences between in vitro conditions used and 
the in vivo conditions of phage selection. 
Predictive Modeling of Modified Cry4Aa-S1 
 Predictive modeling of the modified Cry4Aa-S1 toxins was carried out using 
LOMETS [24] to identify insertion sites predicted to result in display of the peptide 
sequence on the exterior of the toxin.  The models did provide insight on which side, N- 
or C-terminal, of the loops targeted in domain II and domain III would be the most 
exposed.  According to the models, SG3 was more exposed on the C-terminal side of the  
respective loops of Cr4L3 and Cr4B15; while N-terminal insertions resulted in more SG3 
exposure for Cr4L2 and Cr4B12 (Figure 3). 
Modification of Cry4Aa-S1 
The soybean aphid gut binding peptide SG3 was added to seven separate 
addition sites in Cry4Aa, three at the N-terminus, producing a total of seven modified 
toxins (Figure 4).  Each addition was made to a single toxin, i.e. each modified toxin has 
a single addition of SG3 at a single site.  By adding SG3 to three N-terminal locations, we 
increased the probability that one of the additions would remain exposed on the active 
toxin, as the exact cleavage site for the N-terminal peptide is unknown.   The other 
additions were made in loop 2 and loop 3 of domain II, and in the loop formed between 
β12 and β13 and the loop formed between β15 and β16 of domain III.   
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Figure 3.  The predicted structures of the Cry4Aa (PDB accession number: 2C9K) loop-modified toxins, Cr4L2, Cr4L3, Cr4B12, and 
Cr4B15 are shown.  Structures predicted by LOMETS and visualized with PyMol.  SG3 is shown in pink and indicated with an arrow. 
Predictive models that showed SG3 exposed on the surface of the toxin were used for selection of the site for peptide insertion in 
most cases.  Both N- and C- terminal insertions of SG3 into the Cr4B15 site resulted in an inward facing loop.  The C-terminal 
insertion site was selected as it provided the least inward facing peptide. 
6
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Figure 4. SG3 was added via OE-PCR to seven distinct sites in Cry4Aa-S1.  This schematic 
depicts the relative position of each insertion.  SG3 was inserted with the terminal 
cysteines to maintain loop conformation. 
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Upon expression, six out of the seven toxins purified well (see Figure 5 for a 
representative protein gel).  Cr4B12 was not purified at a sufficiently high level for use in 
our experiments, likely due to protein misfolding.  
Structural Stability of Toxins 
To test the structural stability of the modified Cry4Aa-S1 toxins relative to the 
wild-type Cry4Aa-S1, toxins were completely activated using trypsin (Figure 6).  Prior to 
activation with trypsin, wild-type Cry4Aa-S1 yields a 65 kDa band on SDS-PAGE.  After 
activation, Cry4Aa-S1 yields two bands, one at 45 kDa and one at 20 kDa, along with a 
presumed toxin intermediate of  60 kDa [17,25].   
Cry4Aa-S1 yielded 3 bands, as expected, after incubation with trypsin, one 
unprocessed band at 60 kDa, one band at 45 kDa, and one band at 20 kDa.  Four of the 
modified toxins yielded a similar banding pattern, Cr4N1, Cr4N2, Cr4N3, and Cr4B15.  As 
expected, all of the Cry4Aa-S1 toxins modified at the N-terminus were stable.  The N-
terminal additions of SG3 comprised the least invasive modifications of Cry4Aa-S1.  Both 
domain II modified toxins, Cr4L2 and Cr4L3, proved to be unstable.  Cr4L2 and Cr4L3 
showed an unexpected cleavage pattern without incubation with trypsin.  A different 
banding pattern was seen after incubation with trypsin, for Cr4L2 and Cr4L3, indicating 
that at least one trypsin site was functional in these modified toxins.   
Bioassay with Mosquito Larvae 
 Mosquito larval bioassays were conducted to assess the biological activity of the 
modified toxins relative to wild-type Cry4Aa-S1 to assess whether modification had 
impacted toxin structure resulting in loss of native toxicity. 
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Figure 5.  Expression of (a) Cry4Aa-S1 and (b) Cr4N1.  Cry4Aa-S1 was purified from  E. 
coli cell lysate with Glutathione Sepharose 4B.  Purity was assessed by SDS-PAGE. The 
expected size of Cry4Aa-S1 is 65 kDa. 
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Figure 6. Cr4N1, Cr4N2, Cr4N3, and Cr4B15 produce stable, active toxins after trypsin digest.  Trypsin digests were carried out with 5 
μg of each toxin and 5% trypsin (w/w), and then reactions were run on SDS-PAGE.  Undigested toxin shows a primary 65 kDa band 
with an occasional secondary band at 60 kDa.  After incubation with trypsin, 3 bands are present.  Properly activated toxins display 
bands at 45 kDa and 20 kDA.  A proteolytic resistant band runs at approximately 60 kDa.  Boxes indicate faint 20 kDa bands. 
6
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 Due both to the wide range of reported LC50 values for Cry4Aa against C. pipiens 
larvae, and the variation in our own bioassays for toxin treatments, each toxin was 
categorized simply as toxic or non-toxic (Table 3).  Control mortality was minimal 
(<10%). Cry4Aa-S1 was toxic to C. pipiens larvae at a level comparable to published LC50 
data.  In addition to forming a stable active toxin after incubation with trypsin, Cr4B15 
maintained toxicity against C. pipiens larvae.  As expected, due to their instability prior 
to activation, the toxins with SG3 inserted in domain II, Cr4L2 and Cr4L3, did not 
maintain toxicity against C. pipiens larvae, effectively eliminating them from evaluation 
as viable candidates for use against soybean aphid.  Results for bioassays to date using 
Cr4N1, Cr4N2, and Cr4N3 were inconclusive due to high control mortality across 
multiple replicates.  However, it is unlikely that Cr4N1, Cr4N2, or Cr4N3 lost activity 
against C. pipiens larvae as, of the seven constructs, the SG3 insertions into these 
constructs were predicted to be the least disruptive to toxin structure, and these toxins 
were stable on treatment with trypsin.  
Soybean Aphid Bioassay 
 Membrane feeding assays were used to assess toxicity of native Cry4Aa-S1 and 
the candidate modified Cry4Aa-S1 toxins against soybean aphids.  Soybean aphids were 
susceptible to Cry4Aa-S1 when fed on high concentrations of the toxin in complete 
aphid diet.  Analysis by one-way ANOVA with post-hoc Least Square Means (p<0.05) 
showed a statistically significant difference between mortality of soybean aphids fed on 
500 μg/ml of Cry4Aa-S1, and those fed on 125 μg/ml of Cry4Aa-S1 and 500 μg/ml of BSA 
(Figure 7).  Bioassays for N-terminal constructs and Cr4B15 are pending. 
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Table 3. Summary of the structural stability of modified toxins, activity against C. 
pipiens larvae, and whether each toxin was used in soybean aphid bioassays. 
Toxin Stability  Toxicity against C.pipiens Used in A. glycines Assay 
Cry4Aa Yes Yes Yes 
Cr4N1 Yes ? Yes 
Cr4L2 No No No 
Cr4L3 No No No 
Cr4B15 Yes Yes Yes 
Cr4N2 Yes ? Yes 
Cr4N3 Yes ? Yes 
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Figure 7.   At high concentrations Cry4Aa induces mortality in soybean aphid.  Soybean aphids were fed 
several toxin concentrations of Cry4Aa in complete aphid diet.  Two controls were used, complete aphid 
diet alone, and complete aphid diet with 500 μg/ml of BSA to control for the impact of high protein 
concentration on aphid survival. Data shown are from two replicate experiments except for the diet control 
treatment. SE bars are shown. One-way ANOVA with post-hoc Least Square Means was used to assess 
differences. 
6
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Discussion 
Following the successful use of a pea aphid gut binding peptide for enhanced 
binding of Cyt2Aa to the pea aphid gut with associated increased toxicity [23], we 
sought to modify a Cry toxin for use against a major agricultural pest, the soybean 
aphid.  While Cyt toxins have a lipid based mode of action [29], the mode of action of 
Cry toxins is more complex involving multiple binding partners, but is incompletely 
understood [9]. In addition to the potential for toxin modification to enhance toxicity 
against the soybean aphid, this work - particularly the gut protein bound by SG3 and 
whether or not increased binding to those proteins results in enhanced toxicity, may 
also shed light on toxin mode of action.  
Modification of Cry toxin binding has been demonstrated to enhance or bring 
activity against lepidopteran, coleopteran, and dipteran pests [16], as well as against 
hemipteran pests [23,30].  Gut binding peptides can be used to enhance binding to the 
insect gut with a concomitant increase in toxicity against the target insect [23,31].   
A total of eight candidate soybean aphid gut binding peptides were identified 
(SG1-SG8) via an in vivo screen of a phage display library of random peptides against the 
soybean aphid gut, with three consecutive rounds of enrichment for gut binding 
peptides.  Unexpectedly, two of the selected peptides, SG1 and SG2, did not bind to 
whole soybean aphid BBMV in pull-down assays.  The lack of binding of these peptides 
in the in vitro assays might be explained by differences between the in vitro binding 
conditions, and those of the in vivo phage selection conditions. 
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Interestingly, four of the ABP peptides, selected for binding to recombinant 
soybean aphid APN3 under in vitro conditions, had several amino acids in common with 
four of the SG peptides.  The common amino acids were also in similar positions 
between each respective peptide pairing.  Most notable was the similarity between SG3 
and ABP11, with four common amino acids, out of a possible seven, in a similar order.  
Such a degree of similarity supports the hypothesis that SG3 binds to APN3, because  as 
few as three amino acids are necessary for protein - protein interaction [32].  
Experiments are underway to test the hypothesis that SG3 binds APN3.  The uniqueness 
of these similarities is highlighted by the dissimilarity between SG peptides and the PBP 
peptides, selected for in vitro binding to recombinant ALP2.   
As with other proteins, the structure of Cry4Aa is integral to its biological activity 
[17].  Small changes in the structure or sequence of Cry4Aa can result in significant 
changes in activity [17,33,34].  The addition of SG3 to loop 2 and loop 3 of domain II of 
Cry4Aa-S1 resulted in production of unstable toxins.   Addition of five or nine amino acid 
peptides into different loops of domain II of Cry1Ac, either adding to or replacing 
existing sequence, also resulted in production of unstable modified toxins that showed 
no aphid toxicity (Huarong Li, unpublished).  Cr4B12 may also have been unstable:  After 
purification of Cr4B12 a faint 65 kDa band was present after SDS-PAGE, indicating low 
expression, a lack of proper folding, or degradation (data not shown).  Based on the 
available evidence, modifications in domain II of Cry toxins by addition or replacement 
of multiple amino acids are more likely to compromise toxin stability. Delineation of the 
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key amino acids required for receptor binding will allow for more refined toxin 
modification with potentially less impact on toxin structure. 
Increased understanding of Cry toxin structure as it relates to mode of action will 
facilitate identification of sites for modification that are less likely to result in toxin 
instability. Modifications to the N- and C-terminus of activated Cry toxins are the least 
invasive, as peptide insertions, or other modifications, are less likely to impact the core 
toxin structure.  However, to effectively modify Cry toxins at the N- or C-terminus, 
knowledge of the N- and/or C-terminal peptide cleavage sites is required.  While the 
structure of the active form of Cry4Aa is known, the exact cleavage sites of both the N- 
and the C-terminus are unknown. [17]. 
Taken together, our data clearly show that modification of a Cry toxin with a gut 
binding peptide presents more structure- and activity -related challenges than 
modification of a Cyt toxin [23].  This approach does however represent an additional 
potential approach for production of aphid resistant transgenic plants [35]. 
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CHAPTER 3.  CONCLUSIONS & DISCUSSION 
 Insect resistant transgenic crops represent the most rapidly adopted technology 
in modern agriculture.  Since their introduction in the mid-1990s, Bt crops are now 
grown on over one billion acres worldwide [1].  Despite the success of insect resistant, 
transgenic Bt crops, a significant drawback is the low susceptibility of some pest species 
of economic importance to Bt toxins.  Notable among these pests are hemipterans, the 
sap-sucking insects, which include pests such as aphids and stink bugs.  Our ability to 
genetically modify Bt toxins to overcome significant factors inhibiting toxicity against a 
target pest allows for the creation of designer toxins. 
 To date, some effort has been made to modify Bt toxins for toxicity against 
certain hemipterans.  Enhanced binding of Bt toxins to the insect gut, with a 
concomitant increase in toxicity, has been accomplished using the Cyt toxin Cyt2Aa to 
target pea aphid (Acythrosiphon pisum) [2], and the Cry toxin Cry1Ac to target the maize 
leafhopper (Cicadulina mbila) [3].  Both of these approaches resulted in highly active 
toxins.  More moderate success has been observed with the addition of cathepsin 
cleavage sites into Cry4Aa to enhance processing in the pea aphid gut (A. pisum) [4], 
with some evidence for enhanced toxicity against pea aphid. 
Following on from the successful modification of Cyt2Aa with a gut binding 
peptide for targeting of pea aphid [2], the goal of the research described in Chapter 2 
was to engineer a crystal (Cry) toxin using a similar approach. Given the more complex 
and incompletely understood mechanism of action of Cry toxins [5], engineering of 
Cry4Aa using this approach proved more challenging than engineering Cyt2Aa. 
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The modification of Cry4Aa-S1 has provided valuable information however on the 
relationship between the toxin structure and function.  Addition of SG3 to loop 2 or loop 
3 of domain II resulted in two unstable toxins that lost activity against C. pipiens larvae.  
Domain II has proven to be a challenging domain to modify, while examples of unstable 
domain II modifications do not exist in the literature, successful modifications were 
conservative, substituting short amino acid sequences or swapping loops between 
related toxins [6].  More aggressive modifications, like the addition of SG3, in domain II 
might not be feasible, though more work would be needed to confirm this.  However, 
larger modifications may prove unnecessary, as only three amino acids are needed to 
mediate protein-protein interactions [7].  
In contrast to domain II modifications, one of the domain III modified Cry4Aa-S1  
toxins, Cr4B15, maintained structural stability and toxicity against C. pipiens larvae.  
However, when tested against soybean aphid, toxicity was not observed.  At high 
concentrations, Cry4Aa-S1 does cause mortality in soybean aphid, yet Cr4B15 had no 
discernable effect on the health of soybean aphid, in fact, Cr4B15 appears to have lost 
activity against soybean aphid.  This could implicate the importance of domain III to 
Cry4Aa-S1 activity against soybean aphid, though further work would need to be done 
to confirm this. 
N- or C- terminal modifications for Cry4Aa are challenged as the cleavage sites 
for the N- and C-terminal peptides for Cry4Aa-S1 are unknown.  Few Cry toxins have 
cleavage sites identified, in the case of Cry4Aa, the approximate cleavage sites have 
been inferred from the structure of the active toxin, though actual cleavage sites have 
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not been confirmed [8].  Data for the three toxins modified at the N-terminus will 
narrow the position of the cleavage site for the N-terminal peptide. 
The SG – GFP fusion proteins constructed for analysis of peptide interaction with 
the soybean aphid gut were also fed to soybean aphids. Following on from previous 
work with the pea aphid [9], we examined soybean aphids by fluorescence microscopy 
for the presence of the GFP fusion proteins in the soybean aphid gut. The results of 
these experiments are not reported in Chapter 2 because  strong fluorescence was not 
observed, and the source of weak fluorescence when observed was ambiguous 
Insufficient feeding by the soybean aphids on the peptide-GFP fusion proteins may 
explain the ambiguous results.  Recently, Nakasu et al [10] reported that a triple alanine 
linker used for a spider-derived neurotoxin – lectin fusion, was unstable in the Myzus 
persicae gut. In a previous study [11], a proline-rich linker derived from an aphid 
transmitted plant virus was used, and proved to be stable in the aphid gut. For our 
constructs, we used a three glycine linker to link GFP to the candidate gut binding 
peptides. It is possible that this linker was similarly subject to degradation in the 
soybean aphid gut, which would explain why feeding of soybean aphids on the peptide-
GFP fusion proteins did not result in fluorescent soybean aphid guts.   
The introduction of transgenic crops expressing Bt toxins almost 20 years ago 
marked a shift in insect pest management strategies [12].  It is time for another shift in 
how we approach insect pest management.  Instead of only screening environmental 
samples for new toxins, we now have the option to modify characterized toxins to both 
combat the looming specter of field-evolved resistance, and to enhance efficacy against 
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naturally less-susceptible pest species [6,13].  To facilitate Cry toxin engineering, 
increased understanding of Cry toxin mode of action and Cry toxin molecular 
interactions with proteins on the surface of the gut epithelium of the target insect is 
needed so more precise modifications can be made.  Overall, Cry toxin engineering 
provides an adaptive pest management strategy fit for further development. 
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APPENDIX.  NUCLEOTIDE AND AMINO ACID SEQUENCE OF CRY4AA AND 
MODIFIED TOXINS 
SG3 denoted by bolded regions in nucleotide and amino acid sequence. 
Cry4Aa nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCAGGTGAAC
TGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTTTTGGTTTCACCACGCCGCTGGGTCTGGC
ACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCTCAGGACCAAAGCAATACCTGGTCTGATT
TTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGAGTACCTACATCTCCAACGCCAACAAAAT
TCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACCTGAAAACCTGGGAAAACAACCCGAACC
CGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTCATTACCACTTCCAGAACGTGATCCCGGA
ACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTACTACAACATCCTGGTGCTGAGCAGCTAT
GCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCAGTGAAATTCGAAGCGTATCTGAAAAAC
AATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCGATTACTACCCGGTCCTGACGAAAGCTA
TCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGGTCTGAACCTGATCAAAACCACGCCGGA
CTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACGTACCGTACCAAAATGACCACGGCAGTT
CTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAATACCCGATTGGTGTGCAGAGCGAACTGA
CCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGTACAAATATTACGACTTCCAGTACCAAGA
AGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGATAGTCTGAACTTCTACGAAAAAGCACAG
ACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCACTACACCCTGGACAACATTTCACAGAA
AAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAATCTCTGGGTCTGGCTACCAATATTTATA
TCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAACGATTACAACAACATCAGCAAAATGGA
CTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTGACGGCGGGCAGTGGTCAGATCACCTAT
GATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTCGCGAAAACCAGGGTAACCCGACGCTG
TTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAAAGCCTGTCTATCCCGGCAACGTACAA
AACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATCCGAAAAACACGATCTATACCCACCTG
ACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACCGCGTCCAAAGTCGTGCAAGGTCCGGGC
CACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAAATCACCTGCCAGCACTCAAATTTTCAGCA
ATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGCAAACACCCGTGCCGTTATCAACCTGTCTA
TTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACCTTCAGTGGTACGGACTACACCAACCTGA
AATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGAAATTTGCCCCGAATCAAAACATTAGTCT
GGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTGATTGATAAAATCGAATTTCTGCCGATTA
CCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAACCGTGTGA 
Amino Acid  
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSGELS
AYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNANKILNRSFNVIS
TYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYAQAANLHLTVL
NQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGNINWNTYNTY
RTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLFTWLDSLNFY
EKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYLNDYNNISKM
DFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPATYKTQVYTFA
WTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQQSYFIRIRYASN
GSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRSDVYTNTTVLI
DKIEFLPITRSIREDREKQKLETV* 
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Cr4N1 nucleotide and amino acid sequence 
Nucleotide 
TGTATGGGGCATACTTTGGGGAGGTGCATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAAC
GCATCGCAGAAAAAACTGAACATCTCCAACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGC
TGCTGCAATCGACCAACTACAAAGATTGGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACT
TCGAAACGTTCATCGATTCAGGTGAACTGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTTT
TGGTTTCACCACGCCGCTGGGTCTGGCACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCTC
AGGACCAAAGCAATACCTGGTCTGATTTTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGAG
TACCTACATCTCCAACGCCAACAAAATTCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACCT
GAAAACCTGGGAAAACAACCCGAACCCGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTCA
TTACCACTTCCAGAACGTGATCCCGGAACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTACT
ACAACATCCTGGTGCTGAGCAGCTATGCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCAGT
GAAATTCGAAGCGTATCTGAAAAACAATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCGAT
TACTACCCGGTCCTGACGAAAGCTATCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGGTC
TGAACCTGATCAAAACCACGCCGGACTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACGTA
CCGTACCAAAATGACCACGGCAGTTCTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAATAC
CCGATTGGTGTGCAGAGCGAACTGACCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGTAC
AAATATTACGACTTCCAGTACCAAGAAGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGATAG
TCTGAACTTCTACGAAAAAGCACAGACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCACT
ACACCCTGGACAACATTTCACAGAAAAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAATC
TCTGGGTCTGGCTACCAATATTTATATCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAACG
ATTACAACAACATCAGCAAAATGGACTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTGAC
GGCGGGCAGTGGTCAGATCACCTATGATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTCG
CGAAAACCAGGGTAACCCGACGCTGTTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAAA
GCCTGTCTATCCCGGCAACGTACAAAACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATCC
GAAAAACACGATCTATACCCACCTGACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACCGC
GTCCAAAGTCGTGCAAGGTCCGGGCCACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAAATC
ACCTGCCAGCACTCAAATTTTCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGCAAA
CACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACCTTC
AGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGAAAT
TTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTGATT
GATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAACC
GTGTGA 
Amino Acid 
CMGHTLGRCMNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGD
FETFIDSGELSAYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNAN
KILNRSFNVISTYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYA
QAANLHLTVLNQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGN
INWNTYNTYRTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLF
TWLDSLNFYEKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYL
NDYNNISKMDFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPA
TYKTQVYTFAWTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQQ
SYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRS
DVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
 
 83 
Cr4N2 nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCATGTATGG
GGCATACTTTGGGGAGGTGCGGTGAACTGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTT
TTGGTTTCACCACGCCGCTGGGTCTGGCACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCT
CAGGACCAAAGCAATACCTGGTCTGATTTTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGA
GTACCTACATCTCCAACGCCAACAAAATTCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACC
TGAAAACCTGGGAAAACAACCCGAACCCGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTC
ATTACCACTTCCAGAACGTGATCCCGGAACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTA
CTACAACATCCTGGTGCTGAGCAGCTATGCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCA
GTGAAATTCGAAGCGTATCTGAAAAACAATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCG
ATTACTACCCGGTCCTGACGAAAGCTATCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGG
TCTGAACCTGATCAAAACCACGCCGGACTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACG
TACCGTACCAAAATGACCACGGCAGTTCTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAAT
ACCCGATTGGTGTGCAGAGCGAACTGACCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGT
ACAAATATTACGACTTCCAGTACCAAGAAGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGAT
AGTCTGAACTTCTACGAAAAAGCACAGACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCA
CTACACCCTGGACAACATTTCACAGAAAAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAA
TCTCTGGGTCTGGCTACCAATATTTATATCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAA
CGATTACAACAACATCAGCAAAATGGACTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTG
ACGGCGGGCAGTGGTCAGATCACCTATGATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTC
GCGAAAACCAGGGTAACCCGACGCTGTTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAA
AGCCTGTCTATCCCGGCAACGTACAAAACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATC
CGAAAAACACGATCTATACCCACCTGACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACCGC
GTCCAAAGTCGTGCAAGGTCCGGGCCACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAAATC
ACCTGCCAGCACTCAAATTTTCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGCAAA
CACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACCTTC
AGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGAAAT
TTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTGATT
GATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAACC
GTGTGA 
Amino Acid  
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSCMG
HTLGRCGELSAYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNAN
KILNRSFNVISTYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYA
QAANLHLTVLNQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGN
INWNTYNTYRTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLF
TWLDSLNFYEKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYL
NDYNNISKMDFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPA
TYKTQVYTFAWTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQQ
SYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRS
DVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
 
 84 
Cr4N3 nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCAGGTGAAC
TGTGTATGGGGCATACTTTGGGGAGGTGCTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTT
TTGGTTTCACCACGCCGCTGGGTCTGGCACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCT
CAGGACCAAAGCAATACCTGGTCTGATTTTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGA
GTACCTACATCTCCAACGCCAACAAAATTCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACC
TGAAAACCTGGGAAAACAACCCGAACCCGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTC
ATTACCACTTCCAGAACGTGATCCCGGAACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTA
CTACAACATCCTGGTGCTGAGCAGCTATGCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCA
GTGAAATTCGAAGCGTATCTGAAAAACAATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCG
ATTACTACCCGGTCCTGACGAAAGCTATCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGG
TCTGAACCTGATCAAAACCACGCCGGACTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACG
TACCGTACCAAAATGACCACGGCAGTTCTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAAT
ACCCGATTGGTGTGCAGAGCGAACTGACCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGT
ACAAATATTACGACTTCCAGTACCAAGAAGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGAT
AGTCTGAACTTCTACGAAAAAGCACAGACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCA
CTACACCCTGGACAACATTTCACAGAAAAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAA
TCTCTGGGTCTGGCTACCAATATTTATATCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAA
CGATTACAACAACATCAGCAAAATGGACTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTG
ACGGCGGGCAGTGGTCAGATCACCTATGATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTC
GCGAAAACCAGGGTAACCCGACGCTGTTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAA
AGCCTGTCTATCCCGGCAACGTACAAAACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATC
CGAAAAACACGATCTATACCCACCTGACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACCGC
GTCCAAAGTCGTGCAAGGTCCGGGCCACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAAATC
ACCTGCCAGCACTCAAATTTTCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGCAAA
CACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACCTTC
AGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGAAAT
TTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTGATT
GATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAACC
GTGTGA 
Amino Acid  
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSGELC
MGHTLGRCSAYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNAN
KILNRSFNVISTYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYA
QAANLHLTVLNQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGN
INWNTYNTYRTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLF
TWLDSLNFYEKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYL
NDYNNISKMDFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPA
TYKTQVYTFAWTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQQ
SYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRS
DVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
 
 
 85 
Cr4L2 nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCAGGTGAAC
TGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTTTTGGTTTCACCACGCCGCTGGGTCTGGC
ACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCTCAGGACCAAAGCAATACCTGGTCTGATT
TTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGAGTACCTACATCTCCAACGCCAACAAAAT
TCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACCTGAAAACCTGGGAAAACAACCCGAACC
CGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTCATTACCACTTCCAGAACGTGATCCCGGA
ACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTACTACAACATCCTGGTGCTGAGCAGCTAT
GCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCAGTGAAATTCGAAGCGTATCTGAAAAAC
AATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCGATTACTACCCGGTCCTGACGAAAGCTA
TCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGGTCTGAACCTGATCAAAACCACGCCGGA
CTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACGTACCGTACCAAAATGACCACGGCAGTT
CTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAATACCCGATTGGTGTGCAGAGCGAACTGA
CCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGTACAAATATTACGACTTCCAGTACCAAGA
AGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGATAGTCTGAACTTCTACGAAAAAGCACAG
ACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCACTACACCCTGGACAACATTTCACAGAA
AAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAATCTCTGGGTCTGGCTACCAATATTTATA
TCTTTCTGCTGAACGTTATCTGTATGGGGCATACTTTGGGGAGGTGCTCGCTGGACAACAAATACCTGAA
CGATTACAACAACATCAGCAAAATGGACTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTG
ACGGCGGGCAGTGGTCAGATCACCTATGATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTC
GCGAAAACCAGGGTAACCCGACGCTGTTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAA
AGCCTGTCTATCCCGGCAACGTACAAAACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATC
CGAAAAACACGATCTATACCCACCTGACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACCGC
GTCCAAAGTCGTGCAAGGTCCGGGCCACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAAATC
ACCTGCCAGCACTCAAATTTTCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGCAAA
CACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACCTTC
AGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGAAAT
TTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTGATT
GATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAACC
GTGTGA 
Amino Acid 
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSGELS
AYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNANKILNRSFNVIS
TYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYAQAANLHLTVL
NQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGNINWNTYNTY
RTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLFTWLDSLNFY
EKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVICMGHTLGRCSLDNKYL
NDYNNISKMDFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPA
TYKTQVYTFAWTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQQ
SYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRS
DVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
 
 86 
Cr4L3 nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCAGGTGAAC
TGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTTTTGGTTTCACCACGCCGCTGGGTCTGGC
ACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCTCAGGACCAAAGCAATACCTGGTCTGATT
TTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGAGTACCTACATCTCCAACGCCAACAAAAT
TCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACCTGAAAACCTGGGAAAACAACCCGAACC
CGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTCATTACCACTTCCAGAACGTGATCCCGGA
ACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTACTACAACATCCTGGTGCTGAGCAGCTAT
GCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCAGTGAAATTCGAAGCGTATCTGAAAAAC
AATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCGATTACTACCCGGTCCTGACGAAAGCTA
TCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGGTCTGAACCTGATCAAAACCACGCCGGA
CTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACGTACCGTACCAAAATGACCACGGCAGTT
CTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAATACCCGATTGGTGTGCAGAGCGAACTGA
CCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGTACAAATATTACGACTTCCAGTACCAAGA
AGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGATAGTCTGAACTTCTACGAAAAAGCACAG
ACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCACTACACCCTGGACAACATTTCACAGAA
AAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAATCTCTGGGTCTGGCTACCAATATTTATA
TCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAACGATTACAACAACATCAGCAAAATGGA
CTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTGACGGCGGGCAGTGGTCAGATCACCTAT
GATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTCGCGAAAACCAGGGTAACCCGACGCTG
TTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAAAGCCTGTCTATCCCGGCAACGTACAA
ATGTATGGGGCATACTTTGGGGAGGTGCACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGA
TCCGAAAAACACGATCTATACCCACCTGACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACC
GCGTCCAAAGTCGTGCAAGGTCCGGGCCACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAA
ATCACCTGCCAGCACTCAAATTTTCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGC
AAACACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACC
TTCAGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGA
AATTTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTG
ATTGATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAA
CCGTGTGA 
Amino Acid  
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSGELS
AYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNANKILNRSFNVIS
TYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYAQAANLHLTVL
NQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGNINWNTYNTY
RTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLFTWLDSLNFY
EKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYLNDYNNISKM
DFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPATYKCMGHTL
GRCTQVYTFAWTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQ
QSYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNR
SDVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
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Cr4B12 nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCAGGTGAAC
TGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTTTTGGTTTCACCACGCCGCTGGGTCTGGC
ACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCTCAGGACCAAAGCAATACCTGGTCTGATT
TTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGAGTACCTACATCTCCAACGCCAACAAAAT
TCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACCTGAAAACCTGGGAAAACAACCCGAACC
CGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTCATTACCACTTCCAGAACGTGATCCCGGA
ACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTACTACAACATCCTGGTGCTGAGCAGCTAT
GCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCAGTGAAATTCGAAGCGTATCTGAAAAAC
AATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCGATTACTACCCGGTCCTGACGAAAGCTA
TCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGGTCTGAACCTGATCAAAACCACGCCGGA
CTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACGTACCGTACCAAAATGACCACGGCAGTT
CTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAATACCCGATTGGTGTGCAGAGCGAACTGA
CCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGTACAAATATTACGACTTCCAGTACCAAGA
AGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGATAGTCTGAACTTCTACGAAAAAGCACAG
ACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCACTACACCCTGGACAACATTTCACAGAA
AAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAATCTCTGGGTCTGGCTACCAATATTTATA
TCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAACGATTACAACAACATCAGCAAAATGGA
CTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTGACGGCGGGCAGTGGTCAGATCACCTAT
GATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTCGCGAAAACCAGGGTAACCCGACGCTG
TTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAAAGCCTGTCTATCCCGGCAACGTACAA
AACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATCCGAAAAACACGATCTGTATGGGGCAT
ACTTTGGGGAGGTGCTATACCCACCTGACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACC
GCGTCCAAAGTCGTGCAAGGTCCGGGCCACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAA
ATCACCTGCCAGCACTCAAATTTTCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGC
AAACACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACC
TTCAGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGA
AATTTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTG
ATTGATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAA
CCGTGTGA 
Amino Acid  
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSGELS
AYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNANKILNRSFNVIS
TYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYAQAANLHLTVL
NQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGNINWNTYNTY
RTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLFTWLDSLNFY
EKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYLNDYNNISKM
DFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPATYKTQVYTFA
WTHSSVDPKNTICMGHTLGRCYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFQQ
SYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRS
DVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
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Cr4B15 nucleotide and amino acid sequence 
Nucleotide 
ATGAACCCGTATCAAAATAAAAACGAATATGAAACGCTGAACGCATCGCAGAAAAAACTGAACATCTCC
AACAACTACACCCGTTACCCGATCGAAAATTCACCGAAACAGCTGCTGCAATCGACCAACTACAAAGATT
GGCTGAACATGTGCCAGCAAAACCAGCAATACGGTGGTGACTTCGAAACGTTCATCGATTCAGGTGAAC
TGTCGGCATACACCATCGTGGTTGGCACCGTTCTGACGGGTTTTGGTTTCACCACGCCGCTGGGTCTGGC
ACTGATTGGCTTTGGCACCCTGATCCCGGTCCTGTTCCCGGCTCAGGACCAAAGCAATACCTGGTCTGATT
TTATTACCCAGACGAAAAACATCATCAAAAAAGAAATCGCGAGTACCTACATCTCCAACGCCAACAAAAT
TCTGAACCGTAGCTTCAACGTTATCTCTACGTATCATAATCACCTGAAAACCTGGGAAAACAACCCGAACC
CGCAGAACACGCAAGATGTGCGTACCCAGATCCAACTGGTTCATTACCACTTCCAGAACGTGATCCCGGA
ACTGGTTAATAGCTGCCCGCCGAACCCGTCTGATTGTGACTACTACAACATCCTGGTGCTGAGCAGCTAT
GCGCAGGCAGCAAATCTGCATCTGACCGTCCTGAACCAAGCAGTGAAATTCGAAGCGTATCTGAAAAAC
AATCGTCAGTTCGACTATCTGGAACCGCTGCCGACCGCAATCGATTACTACCCGGTCCTGACGAAAGCTA
TCGAAGATTATACCAACTACTGTGTGACCACGTACAAAAAAGGTCTGAACCTGATCAAAACCACGCCGGA
CTCCAACCTGGATGGTAACATCAACTGGAACACCTACAACACGTACCGTACCAAAATGACCACGGCAGTT
CTGGACCTGGTCGCTCTGTTCCCGAACTACGATGTCGGTAAATACCCGATTGGTGTGCAGAGCGAACTGA
CCCGCGAAATCTACCAAGTGCTGAACTTCGAAGAAAGCCCGTACAAATATTACGACTTCCAGTACCAAGA
AGATTCTCTGACGCGTCGTCCGCACCTGTTTACCTGGCTGGATAGTCTGAACTTCTACGAAAAAGCACAG
ACCACGCCGAACAACTTTTTCACGTCCCATTACAACATGTTCCACTACACCCTGGACAACATTTCACAGAA
AAGTTCCGTTTTCGGTAACCACAACGTCACGGATAAACTGAAATCTCTGGGTCTGGCTACCAATATTTATA
TCTTTCTGCTGAACGTTATCTCGCTGGACAACAAATACCTGAACGATTACAACAACATCAGCAAAATGGA
CTTTTTCATCACGAATGGCACCCGTCTGCTGGAAAAAGAACTGACGGCGGGCAGTGGTCAGATCACCTAT
GATGTGAACAAAAACATCTTCGGTCTGCCGATCCTGAAACGTCGCGAAAACCAGGGTAACCCGACGCTG
TTCCCGACCTATGATAACTACTCACATATCCTGTCGTTCATCAAAAGCCTGTCTATCCCGGCAACGTACAA
AACCCAGGTGTACACGTTCGCATGGACCCATTCATCGGTTGATCCGAAAAACACGATCTATACCCACCTG
ACCACGCAGATCCCGGCAGTTAAAGCTAACAGTCTGGGCACCGCGTCCAAAGTCGTGCAAGGTCCGGGC
CACACCGGCGGTGATCTGATCGACTTCAAAGATCATTTCAAAATCACCTGCCAGCACTCAAATTTTTGTAT
GGGGCATACTTTGGGGAGGTGCCAGCAATCGTACTTCATTCGTATCCGCTATGCAAGTAATGGCTCCGC
AAACACCCGTGCCGTTATCAACCTGTCTATTCCGGGCGTCGCAGAACTGGGTATGGCACTGAACCCGACC
TTCAGTGGTACGGACTACACCAACCTGAAATACAAAGATTTCCAGTATCTGGAATTTAGCAATGAAGTGA
AATTTGCCCCGAATCAAAACATTAGTCTGGTGTTCAACCGCTCCGACGTTTACACCAACACCACGGTCCTG
ATTGATAAAATCGAATTTCTGCCGATTACCCGTAGCATCCGTGAAGACCGTGAAAAACAAAAACTGGAAA
CCGTGTGA 
Amino Acid  
MNPYQNKNEYETLNASQKKLNISNNYTRYPIENSPKQLLQSTNYKDWLNMCQQNQQYGGDFETFIDSGELS
AYTIVVGTVLTGFGFTTPLGLALIGFGTLIPVLFPAQDQSNTWSDFITQTKNIIKKEIASTYISNANKILNRSFNVIS
TYHNHLKTWENNPNPQNTQDVRTQIQLVHYHFQNVIPELVNSCPPNPSDCDYYNILVLSSYAQAANLHLTVL
NQAVKFEAYLKNNRQFDYLEPLPTAIDYYPVLTKAIEDYTNYCVTTYKKGLNLIKTTPDSNLDGNINWNTYNTY
RTKMTTAVLDLVALFPNYDVGKYPIGVQSELTREIYQVLNFEESPYKYYDFQYQEDSLTRRPHLFTWLDSLNFY
EKAQTTPNNFFTSHYNMFHYTLDNISQKSSVFGNHNVTDKLKSLGLATNIYIFLLNVISLDNKYLNDYNNISKM
DFFITNGTRLLEKELTAGSGQITYDVNKNIFGLPILKRRENQGNPTLFPTYDNYSHILSFIKSLSIPATYKTQVYTFA
WTHSSVDPKNTIYTHLTTQIPAVKANSLGTASKVVQGPGHTGGDLIDFKDHFKITCQHSNFCMGHTLGRCQQ
SYFIRIRYASNGSANTRAVINLSIPGVAELGMALNPTFSGTDYTNLKYKDFQYLEFSNEVKFAPNQNISLVFNRS
DVYTNTTVLIDKIEFLPITRSIREDREKQKLETV* 
